0000715787 false--01-03 Q3 2020 false 2 98———2.0 6.0—no no 1 3 1 1 0000715787 2019-12-30 2020-10-04 xbrli:shares 0000715787 2020-11-05 iso4217:USD 0000715787 2020-10-04 0000715787 2019-12-29 0000715787 2020-07-06 2020-10-04 0000715787 2019-07-01 2019-09-29 0000715787 2018-12-31 2019-09-29 iso4217:USD xbrli:shares 0000715787 2018-12-30 0000715787 2019-09-29 0000715787 tile:CostofsalesbeforereclassificationMember 2019-07-01 2019-09-29 0000715787 us-gaap:CostOfSalesMember 2019-07-01 2019-09-29 0000715787 tile:SGAAsReportedMember 2019-07-01 2019-09-29 0000715787 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-29 0000715787 tile:CostofsalesbeforereclassificationMember 2018-12-31 2019-09-29 0000715787 us-gaap:CostOfSalesMember 2018-12-31 2019-09-29 0000715787 tile:SGAAsReportedMember 2018-12-31 2019-09-29 0000715787 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-12-31 2019-09-29 xbrli:pure 0000715787 tile:CarpetModularResilientFlooringAndRelatedProductsMember 2019-12-30 2020-10-04 0000715787 tile:InstallationOfCarpetAndOtherFlooringRelatedMaterialMember 2019-12-30 2020-10-04 0000715787 srt:AmericasMember 2019-12-30 2020-10-04 0000715787 srt:AmericasMember 2018-12-31 2019-09-29 0000715787 srt:EuropeMember 2019-12-30 2020-10-04 0000715787 srt:EuropeMember 2018-12-31 2019-09-29 0000715787 srt:AsiaPacificMember 2019-12-30 2020-10-04 0000715787 srt:AsiaPacificMember 2018-12-31 2019-09-29 0000715787 tile:InstallationOfCarpetAndOtherFlooringRelatedMaterialMember 2018-12-31 2019-09-29 0000715787 tile:CarpetModularResilientFlooringAndRelatedProductsMember 2018-12-31 2019-09-29 0000715787 tile:ParticipatingSecuritiesMember 2020-07-06 2020-10-04 0000715787 tile:ParticipatingSecuritiesMember 2019-07-01 2019-09-29 0000715787 tile:ParticipatingSecuritiesMember 2019-12-30 2020-10-04 0000715787 tile:ParticipatingSecuritiesMember 2018-12-31 2019-09-29 0000715787 tile:SyndicatedFacilityAgreementMember 2020-10-04 0000715787 tile:SyndicatedFacilityAgreementMember 2019-12-30 2020-10-04 0000715787 tile:SyndicatedFacilityAgreementMember tile:TermLoanMember 2020-10-04 0000715787 tile:SyndicatedFacilityAgreementMember tile:TermLoanMember 2019-12-29 0000715787 tile:SyndicatedFacilityAgreementMember 2019-12-29 0000715787 tile:OtherLineOfCreditMember 2020-10-04 0000715787 tile:OtherLineOfCreditMember 2019-12-29 0000715787 tile:OtherLineOfCreditMember srt:MinimumMember 2019-12-30 2020-10-04 0000715787 tile:OtherLineOfCreditMember srt:MaximumMember 2019-12-30 2020-10-04 0000715787 tile:OtherLineOfCreditMember srt:MinimumMember 2018-12-31 2019-12-29 0000715787 tile:OtherLineOfCreditMember srt:MaximumMember 2018-12-31 2019-12-29 0000715787 tile:InterestRateSwap1Member 2017-10-01 0000715787 tile:InterestRateSwap2Member 2019-03-31 0000715787 us-gaap:InterestRateSwapMember 2020-10-04 0000715787 us-gaap:ForeignExchangeOptionMember 2020-10-04 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2020-10-04 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2020-10-04 0000715787 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeOptionMember us-gaap:NondesignatedMember 2020-10-04 0000715787 us-gaap:ForeignExchangeOptionMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:NondesignatedMember 2020-10-04 0000715787 us-gaap:OtherCurrentAssetsMember 2020-10-04 0000715787 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2020-10-04 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-12-29 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-12-29 0000715787 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeOptionMember us-gaap:NondesignatedMember 2019-12-29 0000715787 us-gaap:ForeignExchangeOptionMember us-gaap:AccountsPayableAndAccruedLiabilitiesMember us-gaap:NondesignatedMember 2019-12-29 0000715787 us-gaap:OtherCurrentAssetsMember 2019-12-29 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2020-07-06 2020-10-04 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2019-07-01 2019-09-29 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2019-12-30 2020-10-04 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember 2018-12-31 2019-09-29 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2020-07-06 2020-10-04 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-07-01 2019-09-29 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2019-12-30 2020-10-04 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2018-12-31 2019-09-29 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2020-07-06 2020-10-04 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-07-01 2019-09-29 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2019-12-30 2020-10-04 0000715787 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2018-12-31 2019-09-29 0000715787 us-gaap:ForeignExchangeOptionMember us-gaap:OtherExpenseMember us-gaap:NondesignatedMember 2020-07-06 2020-10-04 0000715787 us-gaap:ForeignExchangeOptionMember us-gaap:OtherExpenseMember us-gaap:NondesignatedMember 2019-07-01 2019-09-29 0000715787 us-gaap:ForeignExchangeOptionMember us-gaap:OtherExpenseMember us-gaap:NondesignatedMember 2019-12-30 2020-10-04 0000715787 us-gaap:ForeignExchangeOptionMember us-gaap:OtherExpenseMember us-gaap:NondesignatedMember 2018-12-31 2019-09-29 0000715787 us-gaap:CommonStockMember 2019-12-29 0000715787 us-gaap:AdditionalPaidInCapitalMember 2019-12-29 0000715787 us-gaap:RetainedEarningsMember 2019-12-29 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-29 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-29 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-29 0000715787 us-gaap:RetainedEarningsMember 2019-12-30 2020-04-05 0000715787 us-gaap:CommonStockMember 2019-12-30 2020-04-05 0000715787 us-gaap:AdditionalPaidInCapitalMember 2019-12-30 2020-04-05 0000715787 2019-12-30 2020-04-05 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-30 2020-04-05 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-30 2020-04-05 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-30 2020-04-05 0000715787 us-gaap:CommonStockMember 2020-04-05 0000715787 us-gaap:AdditionalPaidInCapitalMember 2020-04-05 0000715787 us-gaap:RetainedEarningsMember 2020-04-05 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-04-05 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-05 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-04-05 0000715787 us-gaap:RetainedEarningsMember 2020-04-06 2020-07-05 0000715787 us-gaap:CommonStockMember 2020-04-06 2020-07-05 0000715787 us-gaap:AdditionalPaidInCapitalMember 2020-04-06 2020-07-05 0000715787 2020-04-06 2020-07-05 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-04-06 2020-07-05 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2020-04-06 2020-07-05 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-04-06 2020-07-05 0000715787 us-gaap:CommonStockMember 2020-07-05 0000715787 us-gaap:AdditionalPaidInCapitalMember 2020-07-05 0000715787 us-gaap:RetainedEarningsMember 2020-07-05 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-05 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-05 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-07-05 0000715787 us-gaap:RetainedEarningsMember 2020-07-06 2020-10-04 0000715787 us-gaap:CommonStockMember 2020-07-06 2020-10-04 0000715787 us-gaap:AdditionalPaidInCapitalMember 2020-07-06 2020-10-04 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-07-06 2020-10-04 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2020-07-06 2020-10-04 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-07-06 2020-10-04 0000715787 us-gaap:CommonStockMember 2020-10-04 0000715787 us-gaap:AdditionalPaidInCapitalMember 2020-10-04 0000715787 us-gaap:RetainedEarningsMember 2020-10-04 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-10-04 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2020-10-04 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-10-04 0000715787 us-gaap:CommonStockMember 2018-12-30 0000715787 us-gaap:AdditionalPaidInCapitalMember 2018-12-30 0000715787 us-gaap:RetainedEarningsMember 2018-12-30 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-30 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-30 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-30 0000715787 us-gaap:RetainedEarningsMember 2018-12-31 2019-03-31 0000715787 us-gaap:CommonStockMember 2018-12-31 2019-03-31 0000715787 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 2019-03-31 0000715787 2018-12-31 2019-03-31 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 2019-03-31 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 2019-03-31 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2018-12-31 2019-03-31 0000715787 us-gaap:CommonStockMember 2019-03-31 0000715787 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000715787 us-gaap:RetainedEarningsMember 2019-03-31 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-03-31 0000715787 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000715787 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000715787 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000715787 2019-04-01 2019-06-30 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-04-01 2019-06-30 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2019-04-01 2019-06-30 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-04-01 2019-06-30 0000715787 us-gaap:CommonStockMember 2019-06-30 0000715787 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000715787 us-gaap:RetainedEarningsMember 2019-06-30 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-06-30 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2019-06-30 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-06-30 0000715787 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-29 0000715787 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-29 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-07-01 2019-09-29 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2019-07-01 2019-09-29 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-07-01 2019-09-29 0000715787 us-gaap:CommonStockMember 2019-09-29 0000715787 us-gaap:AdditionalPaidInCapitalMember 2019-09-29 0000715787 us-gaap:RetainedEarningsMember 2019-09-29 0000715787 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-29 0000715787 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-29 0000715787 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-09-29 0000715787 us-gaap:EmployeeStockOptionMember 2019-12-30 2020-10-04 0000715787 us-gaap:RestrictedStockMember 2019-12-30 2020-10-04 0000715787 us-gaap:RestrictedStockMember 2018-12-31 2019-09-29 0000715787 us-gaap:RestrictedStockMember 2019-12-29 0000715787 us-gaap:RestrictedStockMember 2020-10-04 0000715787 us-gaap:PerformanceSharesMember srt:MaximumMember 2019-12-30 2020-10-04 0000715787 us-gaap:PerformanceSharesMember 2019-12-30 2020-10-04 0000715787 us-gaap:PerformanceSharesMember 2019-12-29 0000715787 us-gaap:PerformanceSharesMember 2020-10-04 0000715787 us-gaap:PerformanceSharesMember 2018-12-31 2019-09-29 0000715787 tile:RestrictedStockAndPerformanceSharesMember 2019-12-30 2020-10-04 0000715787 us-gaap:EmployeeStockOptionMember 2018-12-31 2019-09-29 0000715787 us-gaap:RestrictedStockMember srt:MinimumMember 2019-12-30 2020-10-04 0000715787 us-gaap:RestrictedStockMember srt:MaximumMember 2019-12-30 2020-10-04 0000715787 us-gaap:PerformanceSharesMember srt:MinimumMember 2019-12-30 2020-10-04 0000715787 srt:MaximumMember 2019-12-30 2020-10-04 0000715787 srt:MinimumMember 2019-12-30 2020-10-04 0000715787 us-gaap:ForeignPlanMember 2020-07-06 2020-10-04 0000715787 us-gaap:ForeignPlanMember 2019-12-30 2020-10-04 0000715787 us-gaap:ForeignPlanMember 2019-07-01 2019-09-29 0000715787 us-gaap:ForeignPlanMember 2018-12-31 2019-09-29 0000715787 tile:SalaryContinuationPlanMember country:US 2020-07-06 2020-10-04 0000715787 tile:SalaryContinuationPlanMember country:US 2019-07-01 2019-09-29 0000715787 tile:SalaryContinuationPlanMember country:US 2019-12-30 2020-10-04 0000715787 tile:SalaryContinuationPlanMember country:US 2018-12-31 2019-09-29 0000715787 tile:NoraDefinedBenefitPlanMember 2020-07-06 2020-10-04 0000715787 tile:NoraDefinedBenefitPlanMember 2019-07-01 2019-09-29 0000715787 tile:NoraDefinedBenefitPlanMember 2019-12-30 2020-10-04 0000715787 tile:NoraDefinedBenefitPlanMember 2018-12-31 2019-09-29 0000715787 2020-04-05 0000715787 srt:EuropeMember us-gaap:OperatingSegmentsMember 2019-12-30 2020-04-05 0000715787 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2019-12-30 2020-04-05 0000715787 srt:AmericasMember us-gaap:OperatingSegmentsMember 2020-07-06 2020-10-04 0000715787 srt:EuropeMember us-gaap:OperatingSegmentsMember 2020-07-06 2020-10-04 0000715787 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2020-07-06 2020-10-04 0000715787 us-gaap:OperatingSegmentsMember 2020-07-06 2020-10-04 0000715787 srt:AmericasMember us-gaap:OperatingSegmentsMember 2020-10-04 0000715787 srt:EuropeMember us-gaap:OperatingSegmentsMember 2020-10-04 0000715787 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2020-10-04 0000715787 us-gaap:OperatingSegmentsMember 2020-10-04 0000715787 srt:AmericasMember us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-29 0000715787 srt:EuropeMember us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-29 0000715787 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-29 0000715787 us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-29 0000715787 srt:AmericasMember us-gaap:OperatingSegmentsMember 2019-12-30 2020-10-04 0000715787 srt:EuropeMember us-gaap:OperatingSegmentsMember 2019-12-30 2020-10-04 0000715787 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2019-12-30 2020-10-04 0000715787 us-gaap:OperatingSegmentsMember 2019-12-30 2020-10-04 0000715787 srt:AmericasMember us-gaap:OperatingSegmentsMember 2018-12-31 2019-09-29 0000715787 srt:EuropeMember us-gaap:OperatingSegmentsMember 2018-12-31 2019-09-29 0000715787 srt:AsiaPacificMember us-gaap:OperatingSegmentsMember 2018-12-31 2019-09-29 0000715787 us-gaap:OperatingSegmentsMember 2018-12-31 2019-09-29 0000715787 us-gaap:CorporateNonSegmentMember 2020-07-06 2020-10-04 0000715787 us-gaap:CorporateNonSegmentMember 2019-07-01 2019-09-29 0000715787 us-gaap:CorporateNonSegmentMember 2019-12-30 2020-10-04 0000715787 us-gaap:CorporateNonSegmentMember 2018-12-31 2019-09-29 0000715787 us-gaap:CorporateNonSegmentMember 2020-10-04 0000715787 srt:ConsolidationEliminationsMember 2020-10-04 0000715787 us-gaap:SubsequentEventMember 2020-10-05 2021-01-03 0000715787 us-gaap:OtherExpenseMember 2020-07-06 2020-10-04 0000715787 us-gaap:OtherExpenseMember 2019-07-01 2019-09-29 0000715787 us-gaap:OtherExpenseMember 2019-12-30 2020-10-04 0000715787 us-gaap:OtherExpenseMember 2018-12-31 2019-09-29 0000715787 tile:A2018and2019RestructuringPlanMember 2020-10-04 0000715787 tile:A2019RestructuringPlanMember 2019-12-23 2019-12-23 tile:office 0000715787 us-gaap:EmployeeSeveranceMember tile:A2019RestructuringPlanMember 2019-12-23 2019-12-23 0000715787 tile:A2019RestructuringPlanMember 2019-09-30 2019-12-29 0000715787 us-gaap:FacilityClosingMember tile:A2019RestructuringPlanMember 2019-09-30 2019-12-29 0000715787 tile:A2019RestructuringPlanMember 2020-10-04 0000715787 us-gaap:EmployeeSeveranceMember tile:A2019RestructuringPlanMember 2019-12-29 0000715787 us-gaap:EmployeeSeveranceMember tile:A2019RestructuringPlanMember 2019-12-30 2020-10-04 0000715787 us-gaap:EmployeeSeveranceMember tile:A2019RestructuringPlanMember 2020-10-04 0000715787 us-gaap:OtherRestructuringMember tile:A2019RestructuringPlanMember 2019-12-29 0000715787 us-gaap:OtherRestructuringMember tile:A2019RestructuringPlanMember 2019-12-30 2020-10-04 0000715787 us-gaap:OtherRestructuringMember tile:A2019RestructuringPlanMember 2020-10-04 0000715787 tile:A2019RestructuringPlanMember 2019-12-29 0000715787 tile:A2019RestructuringPlanMember 2019-12-30 2020-10-04 0000715787 2018-12-29 2018-12-29 0000715787 us-gaap:EmployeeSeveranceMember tile:A2018RestructuringPlanMember 2019-12-29 0000715787 us-gaap:EmployeeSeveranceMember tile:A2018RestructuringPlanMember 2019-12-30 2020-10-04 0000715787 us-gaap:EmployeeSeveranceMember tile:A2018RestructuringPlanMember 2020-10-04 0000715787 tile:A2018RestructuringPlanMember us-gaap:OtherRestructuringMember 2019-12-29 0000715787 tile:A2018RestructuringPlanMember us-gaap:OtherRestructuringMember 2019-12-30 2020-10-04 0000715787 tile:A2018RestructuringPlanMember us-gaap:OtherRestructuringMember 2020-10-04 0000715787 tile:A2018RestructuringPlanMember 2019-12-29 0000715787 tile:A2018RestructuringPlanMember 2019-12-30 2020-10-04 0000715787 tile:A2018RestructuringPlanMember 2020-10-04
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q

☒ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For Quarterly Period Ended October 04, 2020
Commission File Number 001-33994
INTERFACE INC
(Exact name of registrant as specified in its charter)

Georgia |  | 58-1451243
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)

1280 West Peachtree Street, Atlanta, Georgia 30309
(Address of principal executive offices and zip code)
(770) 437-6800
(Registrant’s telephone number, including area code)
Securities Registered Pursuant to Section 12(b) of the Act:

Title of Each Class | Trading Symbol(s) | Name of Each Exchange on Which Registered
Common Stock, $0.10 Par Value Per Share | TILE | Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Date File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

| Large accelerated filer | þ | Accelerated filer | ¨ | Non-accelerated filer | ¨ | Smaller reporting company | ☐ |

Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ
Shares outstanding of each of the registrant’s classes of common stock at November 5, 2020:

Class | Number of Shares
Common Stock, $0.10 par value per share | 58,669,430

Table of Contents
INTERFACE, INC.
INDEX

|  | PAGE
PART I. | FINANCIAL INFORMATION |
| Item 1. | Financial Statements (Unaudited) | 3
|  | Consolidated Condensed Balance Sheets – October 4, 2020 and December 29, 2019 | 3
|  | Consolidated Condensed Statements of Operations - Three Months and Nine Months Ended October 4, 2020 and September 29, 2019 | 4
|  | Consolidated Statements of Comprehensive Income - Three Months and Nine Months Ended Oc tober 4, 2020 and September 29, 2019 | 5
|  | Consolidated Condensed Statements of Cash Flows – Nine Months Ended October 4, 2020 and September 29, 2019 | 6
|  | Notes to Consolidated Condensed Financial Statements | 7
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 30
| Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 37
| Item 4. | Controls and Procedures | 38
PART II. | OTHER INFORMATION |
| Item 1. | Legal Proceedings | 39
| Item 1A. | Risk Factors | 39
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 42
| Item 3. | Defaults Upon Senior Securities | 43
| Item 4. | Mine Safety Disclosures | 43
| Item 5. | Other Information | 43
| Item 6. | Exhibits | 44
SIGNATURE | 45

Table of Contents
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
INTERFACE, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED BALANCE SHEETS
(IN THOUSANDS)

| OCTOBER 4, 2020 |  | DECEMBER 29, 2019
| (UNAUDITED) |  |
ASSETS |  |  |
Current Assets |  |  |
Cash and cash equivalents | $ | 103,719 |  |  | $ | 81,301 |
Accounts receivable, net | 132,592 |  |  | 177,482 |
Inventories, net | 247,494 |  |  | 253,584 |
Prepaid expenses and other current assets | 31,241 |  |  | 35,768 |
Total current assets | 515,046 |  |  | 548,135 |
Property and equipment, net | 346,592 |  |  | 324,585 |
Operating lease right-of-use assets | 99,815 |  |  | 107,044 |
Deferred tax asset | 23,818 |  |  | 19,683 |
Goodwill and intangibles, net | 240,118 |  |  | 346,474 |
Other assets | 80,386 |  |  | 77,128 |
Total assets | $ | 1,305,775 |  |  | $ | 1,423,049 |
LIABILITIES AND SHAREHOLDERS’ EQUITY |  |  |
Current liabilities |  |  |
Accounts payable | $ | 63,781 |  |  | $ | 75,687 |
Accrued expenses | 135,772 |  |  | 140,652 |
Current portion of operating lease liabilities | 14,015 |  |  | 15,914 |
Current portion of long-term debt | 31,239 |  |  | 31,022 |
Total current liabilities | 244,807 |  |  | 263,275 |
Long-term debt | 548,827 |  |  | 565,178 |
Operating lease liabilities | 87,276 |  |  | 91,829 |
Deferred income taxes | 33,378 |  |  | 35,550 |
Other long-term liabilities | 104,467 |  |  | 99,015 |
Total liabilities | 1,018,755 |  |  | 1,054,847 |
Commitments and contingencies |  |  |
Shareholders’ equity |  |  |
Preferred stock | — |  |  | — |
Common stock | 5,867 |  |  | 5,842 |
Additional paid-in capital | 247,012 |  |  | 250,306 |
Retained earnings | 189,533 |  |  | 286,056 |
Accumulated other comprehensive loss – foreign currency translation | (88,822) |  |  | (113,139) |
Accumulated other comprehensive loss – cash flow hedge | (9,790) |  |  | (4,163) |
Accumulated other comprehensive loss – pension liability | (56,780) |  |  | (56,700) |
Total shareholders’ equity | 287,020 |  |  | 368,202 |
Total liabilities and shareholders’ equity | $ | 1,305,775 |  |  | $ | 1,423,049 |

See accompanying notes to consolidated condensed financial statements.
-3-

Table of Contents
INTERFACE, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)

| THREE MONTHS ENDED |  | NINE MONTHS ENDED
| OCTOBER 4, 2020 |  | SEPTEMBER 29, 2019 |  | OCTOBER 4, 2020 |  | SEPTEMBER 29, 2019
NET SALES | $ | 278,642 |  |  | $ | 348,352 |  |  | $ | 826,315 |  |  | $ | 1,003,547 |
Cost of Sales | 176,480 |  |  | 210,608 |  |  | 512,548 |  |  | 608,551 |
GROSS PROFIT ON SALES | 102,162 |  |  | 137,744 |  |  | 313,767 |  |  | 394,996 |
Selling, General and Administrative Expenses | 88,161 |  |  | 93,396 |  |  | 255,902 |  |  | 291,369 |
Restructuring Charges | (1,881) |  |  | 672 |  |  | (3,156) |  |  | 672 |
Goodwill and Intangible Asset Impairment Charge | — |  |  | — |  |  | 121,258 |  |  | — |
OPERATING INCOME (LOSS) | 15,882 |  |  | 43,676 |  |  | (60,237) |  |  | 102,955 |
Interest Expense | 5,426 |  |  | 6,577 |  |  | 16,021 |  |  | 20,180 |
Other Expense | 2,921 |  |  | 1,015 |  |  | 9,551 |  |  | 2,333 |
INCOME (LOSS) BEFORE INCOME TAX EXPENSE | 7,535 |  |  | 36,084 |  |  | (85,809) |  |  | 80,442 |
Income Tax Expense | 1,622 |  |  | 9,874 |  |  | 5,736 |  |  | 17,674 |
NET INCOME (LOSS) | $ | 5,913 |  |  | $ | 26,210 |  |  | $ | (91,545) |  |  | $ | 62,768 |
Earnings (Loss) Per Share – Basic | $ | 0.10 |  |  | $ | 0.45 |  |  | $ | (1.56) |  |  | $ | 1.06 |
Earnings (Loss) Per Share – Diluted | $ | 0.10 |  |  | $ | 0.45 |  |  | $ | (1.56) |  |  | $ | 1.06 |
Common Shares Outstanding – Basic | 58,592 |  |  | 58,433 |  |  | 58,507 |  |  | 59,117 |
Common Shares Outstanding – Diluted | 58,592 |  |  | 58,434 |  |  | 58,507 |  |  | 59,122 |

See accompanying notes to consolidated condensed financial statements.
-4-

Table of Contents
INTERFACE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
(IN THOUSANDS)

| THREE MONTHS ENDED |  | NINE MONTHS ENDED
| OCTOBER 4, 2020 |  | SEPTEMBER 29, 2019 |  | OCTOBER 4, 2020 |  | SEPTEMBER 29, 2019
Net Income (Loss) | $ | 5,913 |  |  | $ | 26,210 |  |  | $ | (91,545) |  |  | $ | 62,768 |
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment | 23,402 |  |  | (18,585) |  |  | 24,317 |  |  | (19,539) |
Other Comprehensive Income (Loss), Cash Flow Hedge | 864 |  |  | (941) |  |  | (5,627) |  |  | (8,914) |
Other Comprehensive Income (Loss), Pension Liability Adjustment | (1,471) |  |  | 1,076 |  |  | (80) |  |  | 1,814 |
Comprehensive Income (Loss) | $ | 28,708 |  |  | $ | 7,760 |  |  | $ | (72,935) |  |  | $ | 36,129 |

See accompanying notes to consolidated condensed financial statements.
-5-

Table of Contents
INTERFACE, INC. AND SUBSIDIARIES
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(IN THOUSANDS)

| NINE MONTHS ENDED
| OCTOBER 4, 2020 |  | SEPTEMBER 29, 2019
OPERATING ACTIVITIES: |  |  |
Net income (loss) | $ | (91,545) |  |  | $ | 62,768 |
Adjustments to reconcile net income (loss) to cash provided by operating activities: |  |  |
Depreciation and amortization | 33,480 |  |  | 33,578 |
Stock compensation amortization expense (benefit) | (1,416) |  |  | 6,494 |
Deferred income taxes and other | (20,438) |  |  | (11,806) |
Amortization of acquired intangible assets | 4,030 |  |  | 4,581 |
Goodwill and intangible asset impairment | 121,258 |  |  | — |
Working capital changes: |  |  |
Accounts receivable | 47,572 |  |  | (928) |
Inventories | 13,203 |  |  | (11,809) |
Prepaid expenses and current assets | 8,819 |  |  | (4,481) |
Accounts payable and accrued expenses | (17,695) |  |  | 11,507 |
CASH PROVIDED BY OPERATING ACTIVITIES | 97,268 |  |  | 89,904 |
INVESTING ACTIVITIES: |  |  |
Capital expenditures | (46,884) |  |  | (53,881) |
Other | (183) |  |  | 85 |
CASH USED IN INVESTING ACTIVITIES | (47,067) |  |  | (53,796) |
FINANCING ACTIVITIES: |  |  |
Repayments of long-term debt | (114,022) |  |  | (65,416) |
Borrowing of long-term debt | 93,000 |  |  | 76,000 |
Tax withholding payments for share-based compensation | (1,505) |  |  | (3,278) |
Proceeds from issuance of common stock | 93 |  |  | 60 |
Debt issuance costs | (1,519) |  |  | — |
Dividends paid | (4,978) |  |  | (11,561) |
Repurchase of common stock | — |  |  | (25,154) |
Finance lease payments | (1,252) |  |  | (808) |
CASH USED IN FINANCING ACTIVITIES | (30,183) |  |  | (30,157) |
Net cash provided by operating, investing and financing activities | 20,018 |  |  | 5,951 |
Effect of exchange rate changes on cash | 2,400 |  |  | (1,728) |
CASH AND CASH EQUIVALENTS: |  |  |
Net change during the period | 22,418 |  |  | 4,223 |
Balance at beginning of period | 81,301 |  |  | 80,989 |
Balance at end of period | $ | 103,719 |  |  | $ | 85,212 |

See accompanying notes to consolidated condensed financial statements.
-6-

Table of Contents
INTERFACE, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
As contemplated by the Securities and Exchange Commission (the “Commission”) instructions to Form 10-Q, the following footnotes have been condensed and, therefore, do not contain all disclosures required in connection with annual financial statements. Reference should be made to the Company’s year-end financial statements and notes thereto contained in its Annual Report on Form 10-K for the fiscal year ended December 29, 2019, as filed with the Commission.
The financial information included in this report has been prepared by the Company, without audit. In the opinion of management, the financial information included in this report contains all adjustments necessary for a fair presentation of the results for the interim periods. All such adjustments are of a normal recurring nature unless otherwise disclosed. Nevertheless, the results shown for interim periods are not necessarily indicative of results to be expected for the full year. The December 29, 2019, consolidated condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States (“GAAP”).
The nine month period ended October 4, 2020 includes 40 weeks, and the nine month period ended September 29, 2019 includes 39 weeks. The three month periods ended October 4, 2020 and September 29, 2019 both include 13 weeks.
Risks and Uncertainties
The World Health Organization declared the COVID-19 outbreak a pandemic, and many companies have experienced disruptions in their operations. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that, except for the goodwill and intangible asset impairment discussed in Note 10 “Goodwill and Intangible Assets,” the decline in 2020 revenue, and its consequent impacts on production volume, operating income, net income, cash flows, and order rates, there were no other material adverse impacts on the Company’s results of operations and financial position at October 4, 2020. The Company’s primary credit facility has various financial and other covenants including, but not limited to, a covenant to not exceed a maximum net debt to EBITDA ratio, as defined by the credit facility agreement. On July 15, 2020, the Company amended its Syndicated Credit Facility; see Note 5 entitled “Long-Term Debt” for additional information. The full extent of the future impact of COVID-19 on the Company’s operations is uncertain. A prolonged COVID-19 pandemic may continue to have a material adverse impact on our operations, financial condition, and supply chains. It may negatively impact our ability to collect outstanding receivables, manage inventory, and service customers. The impact of COVID-19 could result in additional impairment losses related to goodwill, intangible assets, and property, plant and equipment.
As the virus spreads through communities, it could impact the physical health, mental health, and productivity of our workforce as many of them are required to shelter in place and work from home for prolonged periods of time, and it could also impact our ability to reach our customers and collaborate with them as they are required to shelter in place and work from home for prolonged periods of time. The COVID-19 pandemic is having broad and negative implications on the global economy, which affects the size and timing of our customers’ capital budgets, and could result in delays or terminations of new and existing renovation projects, remodeling projects, new construction projects, and other projects where our products are used.
COVID-19 Impact
We continue to monitor our operations and have implemented various programs to mitigate the effects of COVID-19 on our business including reductions in employee headcount, labor costs, marketing expenses, consulting spend, travel costs, various other costs, and capital expenditures, as well as suspending and reducing shifts in our production facilities, temporarily furloughing employees, and implementing other cost reduction or avoidance initiatives. Government grants and payroll protection programs are available globally to provide assistance to companies impacted by the pandemic. The Coronavirus Aid, Relief and Economic Security Act (“CARES Act”) enacted in the United States (see Note 13 entitled “Income Taxes” for additional information) and a payroll protection program enacted in the Netherlands (the “NOW Program”) provide benefits related to payroll costs either as reimbursements, lower payroll tax rates or deferral of payroll tax payments. The NOW Program provides eligible companies with reimbursement of labor costs as an incentive to retain employees on the payroll. During fiscal year 2020 year to date, the Company recognized benefits under several payroll protection programs as reductions to payroll costs.
-7-

Table of Contents
Reclassifications
In fiscal year 2020, the Company made certain classification and presentation changes related to customer service and other costs. Previously, these costs were presented as a component of cost of sales. Beginning in fiscal year 2020, these costs are presented as a component of selling, general and administrative (“SG&A”) expense. The Company determined that this change better reflects how management views and operates the business. Reclassifications of the comparative prior year 2019 amounts have been made to conform to the current presentation as follows:

|  | Three Months Ended September 29, 2019
Statement of Operations Line Item |  | As Reported |  | Reclassification |  | As Reclassified
|  | (In thousands)
Cost of Sales |  | $ | 212,590 |  |  | $ | (1,982) |  |  | $ | 210,608 |
Selling, General and Administrative Expenses |  | 91,414 |  |  | 1,982 |  |  | 93,396 |
Total |  | $ | 304,004 |  |  | $ | — |  |  | $ | 304,004 |
|  | Nine Months Ended September 29, 2019
Statement of Operations Line Item |  | As Reported |  | Reclassification |  | As Reclassified
|  | (In thousands)
Cost of Sales |  | $ | 613,797 |  |  | $ | (5,246) |  |  | $ | 608,551 |
Selling, General and Administrative Expenses |  | 286,123 |  |  | 5,246 |  |  | 291,369 |
Total |  | $ | 899,920 |  |  | $ | — |  |  | $ | 899,920 |

Recently Adopted Accounting Pronouncements
On December 30, 2019, the Company adopted Accounting Standards Codification (“ASC”) Topic 326, Credit Losses. This standard requires a financial asset (including trade receivables) to be presented at the net amount expected to be collected through the use of valuation allowances for credit losses. The income statement will reflect the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. The Company adopted the new standard using a modified retrospective approach with no cumulative-effect adjustment to retained earnings to recognize expected credit losses on trade accounts receivable. The adoption of this standard did not have a material impact to the Company’s consolidated financial statements.
On December 30, 2019, the Company adopted Accounting Standards Update (“ASU”) 2017-04, “Intangibles - Goodwill and Other,” that provides for the elimination of Step 2 from the goodwill impairment test. Under the new guidance, impairment charges are recognized to the extent the carrying amount of a reporting unit exceeds its fair value with certain limitations. See Note 10 entitled “Goodwill and Intangible Assets” for additional information.
On December 30, 2019, the Company adopted ASU 2018-13, “Changes to the Disclosure Requirements for Fair Value Measurement.” This standard eliminates the current requirement to disclose the amount or reason for transfers between level 1 and level 2 of the fair value hierarchy and the requirement to disclose the valuation methodology for level 3 fair value measurements. The standard includes additional disclosure requirements for level 3 fair value measurements, including the requirement to disclose the changes in unrealized gains and losses in other comprehensive income during the period and permits the disclosure of other relevant quantitative information for certain unobservable inputs. The adoption of this standard did not have a material impact to the Company’s consolidated financial statements.
On December 30, 2019, the Company adopted ASU 2018-15, “Internal-Use Software - Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement.” This ASU aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement service contract with the guidance to capitalize implementation costs of internal use software. The ASU also requires that the costs for implementation activities during the application development phase be capitalized in a hosting arrangement service contract, and costs during the preliminary and post implementation phase are expensed. The Company adopted this standard, which will be applied on a prospective basis, with no material impact to the Company’s consolidated financial statements.
-8-

Table of Contents
Recently Issued Accounting Pronouncements Not Yet Adopted
In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, “Simplifying the Accounting for Income Taxes.” The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles in ASC Topic 740 related to intraperiod tax allocation, the calculation of income taxes in interim periods, and the accounting for outside basis differences of foreign subsidiaries and equity method investments. The amendments also improve consistent application of and simplify GAAP for other areas of ASC Topic 740, including franchise or similar taxes partially based on income, the accounting for a step-up in tax basis goodwill, and interim recognition of an enacted change in tax laws or rates, by clarifying and amending existing guidance. This new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company is currently evaluating the impact of adoption of this standard but does not anticipate that the adoption will have a material effect on its consolidated financial statements.
In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” This standard addresses the risks from the discontinuation of the London Interbank Offered Rate (LIBOR) and provides optional expedients and exceptions to contracts, hedging relationships and other transactions that reference LIBOR if certain criteria are met. This new guidance is effective and may be applied beginning March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of adoption of this standard.
-9-

Table of Contents
NOTE 2 – REVENUE RECOGNITION
Revenue from sales of carpet, modular resilient flooring, rubber flooring, and other flooring-related material was approximately 98% of total revenue for both nine month periods ended October 4, 2020 and September 29, 2019. The remaining 2% of revenue was generated from the installation of carpet and other flooring-related material for both the 2020 and 2019 nine month periods.
Disaggregation of Revenue
For the nine months ended October 4, 2020 and September 29, 2019, revenue from the Company’s customers is broken down by geography as follows:

| Nine Months Ended
Geography | October 4, 2020 |  | September 29, 2019
Americas | 54.7% |  | 56.2%
Europe | 31.4% |  | 29.4%
Asia-Pacific | 13.9% |  | 14.4%

-10-

Table of Contents
NOTE 3 – INVENTORIES
Inventories are summarized as follows:

| October 4, 2020 |  | December 29, 2019
| (In thousands)
Finished Goods | $ | 170,576 |  |  | $ | 184,336 |
Work in Process | 17,657 |  |  | 13,152 |
Raw Materials | 59,261 |  |  | 56,096 |
Inventories, net | $ | 247,494 |  |  | $ | 253,584 |

-11-

Table of Contents
NOTE 4 – EARNINGS PER SHARE
The Company computes basic earnings or loss per share (“EPS”) by dividing net income or loss by the weighted average common shares outstanding, including participating securities outstanding, during the period as discussed below. Diluted EPS reflects the potential dilution beyond shares for basic EPS that could occur if securities or other contracts to issue common stock were exercised, converted into common stock or resulted in the issuance of common stock that would have shared in the Company’s earnings.
The Company includes all unvested stock awards which contain non-forfeitable rights to dividends or dividend equivalents, whether paid or unpaid, in the number of shares outstanding in the basic and diluted EPS calculations when the inclusion of these shares would be dilutive. Unvested share-based awards of restricted stock are paid dividends equally with all other shares of common stock. As a result, the Company includes all outstanding restricted stock awards in the calculation of basic and diluted EPS. Distributed earnings include common stock dividends and dividends earned on unvested share-based payment awards. Undistributed earnings represent earnings that were available for distribution but were not distributed. The following tables show distributed and undistributed earnings:

| Three Months Ended |  | Nine Months Ended
Earnings (Loss) Per Share | October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
Basic Earnings (Loss) Per Share: |  |  |  |  |  |  |
Distributed Earnings | $ | 0.01 |  |  | $ | 0.07 |  |  | $ | 0.09 |  |  | $ | 0.19 |
Undistributed Earnings (Loss) | 0.09 |  |  | 0.38 |  |  | (1.65) |  |  | 0.87 |
Total | $ | 0.10 |  |  | $ | 0.45 |  |  | $ | (1.56) |  |  | $ | 1.06 |
Diluted Earnings (Loss) Per Share: |  |  |  |  |  |  |
Distributed Earnings | $ | 0.01 |  |  | $ | 0.07 |  |  | $ | 0.09 |  |  | $ | 0.19 |
Undistributed Earnings (Loss) | 0.09 |  |  | 0.38 |  |  | (1.65) |  |  | 0.87 |
Total | $ | 0.10 |  |  | $ | 0.45 |  |  | $ | (1.56) |  |  | $ | 1.06 |
Basic Earnings (Loss) Per Share | $ | 0.10 |  |  | $ | 0.45 |  |  | $ | (1.56) |  |  | $ | 1.06 |
Diluted Earnings (Loss) Per Share | $ | 0.10 |  |  | $ | 0.45 |  |  | $ | (1.56) |  |  | $ | 1.06 |

The following table presents net income that was attributable to participating securities:

| Three Months Ended |  | Nine Months Ended
| October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
| (In millions)
Net Income Attributable to Participating Securities | $ | — |  |  | $ | 0.2 |  |  | $ | — |  |  | $ | 0.6 |

The weighted average shares for basic and diluted EPS were as follows:

| Three Months Ended |  | Nine Months Ended
| October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
| (In thousands)
Weighted Average Shares Outstanding | 58,140 |  |  | 57,915 |  |  | 58,055 |  |  | 58,599 |
Participating Securities | 452 |  |  | 518 |  |  | 452 |  |  | 518 |
Shares for Basic EPS | 58,592 |  |  | 58,433 |  |  | 58,507 |  |  | 59,117 |
Dilutive Effect of Stock Options | — |  |  | 1 |  |  | — |  |  | 5 |
Shares for Diluted EPS | 58,592 |  |  | 58,434 |  |  | 58,507 |  |  | 59,122 |

For all periods presented, there were no stock options or participating securities excluded from the computation of diluted EPS.
-12-

Table of Contents
NOTE 5 – LONG-TERM DEBT
Syndicated Credit Facility
On July 15, 2020, the Company entered into a second amendment to its Syndicated Credit Facility (the “Facility”). This amendment, among other changes, provides for the following: (1) amends the consolidated net leverage ratio covenant making it less restrictive for a period of seven consecutive fiscal quarters beginning with the third quarter of fiscal year 2020 through the first quarter of fiscal year 2022 (the “Relief Period”); (2) amends the pricing grid used to determine interest rate margins on outstanding loans as well as the commitment fee on the unused portion of the Facility to include additional consolidated net leverage ratio levels with increased pricing at higher levels of leverage; (3) amends interest rate provisions to provide for an interest rate floor of either 0.00% or 0.75%, as applicable, on certain tranches of term loans outstanding; and (4) provides temporary restrictions during the Relief Period on the Company’s ability to make acquisitions, pay dividends, repurchase shares, or enter into new credit facilities without lender consent. The Company incurred approximately $1.5 million in debt issuance costs to execute this amendment.
The Facility provides the Company and certain of its subsidiaries a multicurrency revolving loan and U.S. denominated and multicurrency term loans. Interest on base rate loans is charged at varying rates computed by applying a margin depending on the Company’s consolidated net leverage ratio as of the most recently completed fiscal quarter. Interest on LIBOR-based loans and fees for letters of credit is charged at varying rates computed by applying a margin over the applicable LIBOR rate, depending on the Company’s consolidated net leverage ratio as of the most recently completed fiscal quarter. In addition, the Company pays a commitment fee per annum (depending on the Company’s consolidated net leverage ratio as of the most recently completed fiscal quarter) on the unused portion of the Facility.
As of October 4, 2020, the Company had outstanding $562.3 million of term loan borrowing and $23.7 million of revolving loan borrowings under the Facility, and had $1.6 million in letters of credit outstanding under the Facility. As of December 29, 2019, the Company had outstanding $581.6 million of term loan borrowing and $20.9 million of revolving loan borrowings under the Facility, and had $2.2 million in letters of credit outstanding under the Facility. As of October 4, 2020 and December 29, 2019, the weighted average interest rate on borrowings outstanding under the Facility was 3.15% and 3.27%, respectively. As of October 4, 2020 and December 29, 2019, the carrying value of the Company’s borrowings under the Facility approximates its fair value as the Facility bears interest rates that are similar to existing market rates.
Under the Facility, the Company is required to make quarterly amortization payments of the term loan borrowings, which are due on the last day of the calendar quarter.
The Company is currently in compliance with all covenants under the Facility and anticipates that it will remain in compliance with the covenants for the foreseeable future.
Debt issuance costs associated with term loans are reflected as a reduction of long-term debt in accordance with applicable accounting standards. As these fees are expensed over the life of the outstanding borrowing, the debt balance will increase by the same amount as the fees that are expensed. As of October 4, 2020 and December 29, 2019, the unamortized debt issuance costs recorded as a reduction of long-term debt were $5.9 million and $6.3 million, respectively.
Other deferred borrowing costs, which include underwriting, legal and other direct costs related to the issuance of revolving debt, net of accumulated amortization, were $1.5 million and $1.3 million as of October 4, 2020 and December 29, 2019, respectively. These amounts are included in other assets in the Company’s consolidated condensed balance sheets. The Company amortizes these costs over the life of the related debt.
Other Lines of Credit
Subsidiaries of the Company had an aggregate of the equivalent of $9.6 million and $9.5 million of other lines of credit available as of October 4, 2020 and December 29, 2019, respectively, at interest rates ranging from 2.0% to 6.0% as of both October 4, 2020 and December 29, 2019. As of October 4, 2020 and December 29, 2019, there were no borrowings outstanding under these lines of credit.
-13-

Table of Contents
NOTE 6 – DERIVATIVE INSTRUMENTS
Interest Rate Risk Management
In the third quarter of 2017 and the first quarter of 2019, the Company entered into interest rate swap transactions in notional amounts of $100 million and $150 million, respectively, to fix the variable interest rate on a portion of its term loan borrowing in order to manage a portion of its exposure to interest rate fluctuations. The Company’s objective and strategy with respect to these interest rate swaps is to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability to cash flows relating to interest payments on a portion of its outstanding debt. The Company is meeting its objective by hedging the risk of changes in its cash flows (interest payments) attributable to changes in LIBOR, the designated benchmark interest rate being hedged (the “hedged risk”), on an amount of the Company’s debt principal equal to the outstanding swap notional amounts.
Cash Flow Interest Rate Swaps
Both of the interest rate swaps described above are designated and qualify as cash flow hedges of forecasted interest payments. The Company reports the changes in fair value of the swaps as a component of other comprehensive income (or other comprehensive loss). The aggregate notional amount of the interest rate swaps as of October 4, 2020 was $250 million.
Forward Contracts
Our European operations, from time to time, are party to currency forward contracts designed to hedge the cash flow risk of intercompany sales from the manufacturing facility in Europe to the Americas. The Company’s objective and strategy with respect to these currency forward contracts is to protect the Company against adverse fluctuations in currency rates by reducing its exposure to variability in cash flows related to receipt of payment on intercompany sales. As of October 4, 2020, there were no active forward currency contracts.
Derivative Transactions Not Designated as Hedging Instruments
Our Asia-Pacific operations, from time to time, purchase foreign currency options to economically hedge inventory purchases denominated in foreign currencies other than their functional currency. The Company’s objective with respect to these foreign currency options is to protect the Company against adverse fluctuations in currency rates by reducing its exposure to variability in cash flows related to payment on inventory purchases. These options are classified as non-designated derivative instruments. Gains and losses on the changes in fair value of these foreign currency options are recognized in earnings each period. As of October 4, 2020, the Company had outstanding foreign currency options with an aggregate notional amount of $16.9 million.
The table below sets forth the fair value of derivative instruments as of October 4, 2020:

| Asset Derivatives as of October 4, 2020 |  | Liability Derivatives as of October 4, 2020
| Balance Sheet Location |  | Fair Value |  | Balance Sheet Location |  | Fair Value
| (In thousands)
Derivative instruments designated as hedging instruments: |  |  |  |  |  |  |
Interest rate swap contracts | Other current assets |  | $ | — |  |  | Accrued expenses |  | $ | 13,685 |
Derivative instruments not designated as hedging instruments: |  |  |  |  |  |  |
Foreign currency options | Other current assets |  | 232 |  |  | Accrued expenses |  | — |
|  |  | $ | 232 |  |  |  |  | $ | 13,685 |

-14-

Table of Contents
The table below sets forth the fair value of derivative instruments as of December 29, 2019:

| Asset Derivatives as of December 29, 2019 |  | Liability Derivatives as of December 29, 2019
| Balance Sheet Location |  | Fair Value |  | Balance Sheet Location |  | Fair Value
| (In thousands)
Derivative instruments designated as hedging instruments: |  |  |  |  |  |  |
Interest rate swap contracts | Other current assets |  | $ | — |  |  | Accrued expenses |  | $ | 5,801 |
Derivative instruments not designated as hedging instruments: |  |  |  |  |  |  |
Foreign currency options | Other current assets |  | 251 |  |  | Accrued expenses |  | — |
|  |  | $ | 251 |  |  |  |  | $ | 5,801 |

We expect that approximately $5.2 million related to cash flow hedges will be reclassified from accumulated other comprehensive loss as an increase to interest expense in the next 12 months.
The following table summarizes the impact that changes in the fair value of derivatives designated as cash flow hedges had on accumulated other comprehensive loss, net of tax, during the three and nine months ended October 4, 2020 and September 29, 2019:

| Three Months Ended |  | Nine Months Ended
| October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
| (In thousands)
Foreign currency contracts gain | $ | — |  |  | $ | 627 |  |  | $ | — |  |  | $ | 468 |
Interest rate swap contracts gain (loss) | 864 |  |  | (1,568) |  |  | (5,627) |  |  | (9,382) |
Gain (loss) recognized in accumulated other comprehensive loss | $ | 864 |  |  | $ | (941) |  |  | $ | (5,627) |  |  | $ | (8,914) |

Gains and losses from derivatives designated as cash flow hedges reclassified from accumulated other comprehensive income (loss) into net income (loss) are discussed in Note 14 entitled “Items Reclassified From Accumulated Other Comprehensive Loss.”
The following tables summarize gains and losses on derivatives not designated as hedging instruments within the consolidated condensed statements of operations for the three and nine months ended October 4, 2020 and September 29, 2019:

|  |  | Three Months Ended
| Statement of Operations Location |  | October 4, 2020 |  | September 29, 2019
|  |  | (In thousands)
Foreign currency options gain (loss) | Other expense |  | $ | 11 |  |  | $ | 325 |
|  |  | Nine Months Ended
| Statement of Operations Location |  | October 4, 2020 |  | September 29, 2019
|  |  | (In thousands)
Foreign currency options gain (loss) | Other expense |  | $ | 90 |  |  | $ | (224) |

-15-

Table of Contents
NOTE 7 – SHAREHOLDERS’ EQUITY
The following tables depict the activity in the accounts which make up shareholders’ equity for the three and nine months ended October 4, 2020 and September 29, 2019:

| SHARES |  | COMMON STOCK |  | ADDITIONAL PAID-IN CAPITAL |  | RETAINED EARNINGS |  | PENSION LIABILITY |  | FOREIGN CURRENCY TRANSLATION ADJUSTMENT |  | CASH FLOW HEDGE
| (In thousands)
Balance, at December 29, 2019 | 58,416 |  |  | $ | 5,842 |  |  | $ | 250,306 |  |  | $ | 286,056 |  |  | $ | (56,700) |  |  | $ | (113,139) |  |  | $ | (4,163) |
Net loss | — |  |  | — |  |  | — |  |  | (102,167) |  |  | — |  |  | — |  |  | — |
Stock issuances under employee plans | 220 |  |  | 22 |  |  | 197 |  |  | — |  |  | — |  |  | — |  |  | — |
Other issuances of common stock | 107 |  |  | 10 |  |  | 1,720 |  |  | — |  |  | — |  |  | — |  |  | — |
Unamortized stock compensation expense related to restricted stock awards | — |  |  | — |  |  | (1,731) |  |  | — |  |  | — |  |  | — |  |  | — |
Cash dividends declared, $0.065 per common share | — |  |  | — |  |  | — |  |  | (3,807) |  |  | — |  |  | — |  |  | — |
Forfeitures and compensation expense related to stock awards | (255) |  |  | (25) |  |  | (4,114) |  |  | — |  |  | — |  |  | — |  |  | — |
Pension liability adjustment | — |  |  | — |  |  | — |  |  | — |  |  | 1,733 |  |  | — |  |  | — |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (15,245) |  |  | — |
Cash flow hedge unrealized loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (6,140) |
Balance, at April 5, 2020 | 58,488 |  |  | $ | 5,849 |  |  | $ | 246,378 |  |  | $ | 180,082 |  |  | $ | (54,967) |  |  | $ | (128,384) |  |  | $ | (10,303) |
Net income | — |  |  | — |  |  | — |  |  | 4,709 |  |  | — |  |  | — |  |  | — |
Stock issuances under employee plans | 12 |  |  | 1 |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |
Other issuances of common stock | 70 |  |  | 7 |  |  | 2,294 |  |  | — |  |  | — |  |  | — |  |  | — |
Unamortized stock compensation expense related to restricted stock awards | — |  |  | — |  |  | (2,300) |  |  | — |  |  | — |  |  | — |  |  | — |
Cash dividends declared, $0.01 per common share | — |  |  | — |  |  | — |  |  | (585) |  |  | — |  |  | — |  |  | — |
Forfeitures and compensation expense related to stock awards | (26) |  |  | (3) |  |  | (48) |  |  | — |  |  | — |  |  | — |  |  | — |
Pension liability adjustment | — |  |  | — |  |  | — |  |  | — |  |  | (342) |  |  | — |  |  | — |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 16,160 |  |  | — |
Cash flow hedge unrealized loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (351) |
Balance, at July 5, 2020 | 58,544 |  |  | $ | 5,854 |  |  | $ | 246,323 |  |  | $ | 184,206 |  |  | $ | (55,309) |  |  | $ | (112,224) |  |  | $ | (10,654) |
Net income | — |  |  | — |  |  | — |  |  | 5,913 |  |  | — |  |  | — |  |  | — |
Stock issuances under employee plans | 7 |  |  | 1 |  |  | (1) |  |  | — |  |  | — |  |  | — |  |  | — |
Other issuances of common stock | 127 |  |  | 13 |  |  | (15) |  |  | — |  |  | — |  |  | — |  |  | — |
Unamortized stock compensation expense related to restricted stock awards | — |  |  | — |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | — |
Cash dividends declared, $0.01 per common share | — |  |  | — |  |  | — |  |  | (586) |  |  | — |  |  | — |  |  | — |
Forfeitures and compensation expense related to stock awards | (8) |  |  | (1) |  |  | 703 |  |  | — |  |  | — |  |  | — |  |  | — |
Pension liability adjustment | — |  |  | — |  |  | — |  |  | — |  |  | (1,471) |  |  | — |  |  | — |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 23,402 |  |  | — |
Cash flow hedge unrealized loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 864 |
Balance, at October 4, 2020 | 58,670 |  |  | $ | 5,867 |  |  | $ | 247,012 |  |  | $ | 189,533 |  |  | $ | (56,780) |  |  | $ | (88,822) |  |  | $ | (9,790) |

-16-

Table of Contents

| SHARES |  | COMMON STOCK |  | ADDITIONAL PAID-IN CAPITAL |  | RETAINED EARNINGS |  | PENSION LIABILITY |  | FOREIGN CURRENCY TRANSLATION ADJUSTMENT |  | CASH FLOW HEDGE
| (In thousands)
Balance, at December 30, 2018 | 59,508 |  |  | $ | 5,951 |  |  | $ | 270,269 |  |  | $ | 222,214 |  |  | $ | (43,610) |  |  | $ | (101,487) |  |  | $ | 1,326 |
Net income | — |  |  | — |  |  | — |  |  | 7,059 |  |  | — |  |  | — |  |  | — |
Stock issuances under employee plans | 509 |  |  | 51 |  |  | 379 |  |  | — |  |  | — |  |  | — |  |  | — |
Other issuances of common stock | 224 |  |  | 22 |  |  | 3,900 |  |  | — |  |  | — |  |  | — |  |  | — |
Unamortized stock compensation expense related to restricted stock awards | — |  |  | — |  |  | (3,922) |  |  | — |  |  | — |  |  | — |  |  | — |
Cash dividends declared, $0.065 per common share | — |  |  | — |  |  | — |  |  | (3,900) |  |  | — |  |  | — |  |  | — |
Forfeitures and compensation expense related to stock awards | (225) |  |  | (22) |  |  | 29 |  |  | — |  |  | — |  |  | — |  |  | — |
Pension liability adjustment | — |  |  | — |  |  | — |  |  | — |  |  | (91) |  |  | — |  |  | — |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (5,203) |  |  | — |
Cash flow hedge unrealized loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (3,306) |
Balance, at March 31, 2019 | 60,016 |  |  | $ | 6,002 |  |  | $ | 270,655 |  |  | $ | 225,373 |  |  | $ | (43,701) |  |  | $ | (106,690) |  |  | $ | (1,980) |
Net income | — |  |  | — |  |  | — |  |  | 29,499 |  |  | — |  |  | — |  |  | — |
Stock issuances under employee plans | 2 |  |  | — |  |  | 6 |  |  | — |  |  | — |  |  | — |  |  | — |
Other issuances of common stock | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Unamortized stock compensation expense related to restricted stock awards | — |  |  | — |  |  | 52 |  |  | — |  |  | — |  |  | — |  |  | — |
Cash dividends declared, $0.065 per common share | — |  |  | — |  |  | — |  |  | (3,863) |  |  | — |  |  | — |  |  | — |
Forfeitures and compensation expense related to stock awards | (28) |  |  | (3) |  |  | 1,506 |  |  | — |  |  | — |  |  | — |  |  | — |
Share repurchases | (1,556) |  |  | (156) |  |  | (24,998) |  |  | — |  |  | — |  |  | — |  |  | — |
Pension liability adjustment | — |  |  | — |  |  | — |  |  | — |  |  | 829 |  |  | — |  |  | — |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 4,249 |  |  | — |
Cash flow hedge unrealized loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (4,667) |
Balance, at June 30, 2019 | 58,433 |  |  | $ | 5,843 |  |  | $ | 247,221 |  |  | $ | 251,009 |  |  | $ | (42,872) |  |  | $ | (102,441) |  |  | $ | (6,647) |
Net income | — |  |  | — |  |  | — |  |  | 26,210 |  |  | — |  |  | — |  |  | — |
Cash dividends declared, $0.065 per common share | — |  |  | — |  |  | — |  |  | (3,798) |  |  | — |  |  | — |  |  | — |
Forfeitures and compensation expense related to stock awards | — |  |  | — |  |  | 1,303 |  |  | — |  |  | — |  |  | — |  |  | — |
Pension liability adjustment | — |  |  | — |  |  | — |  |  | — |  |  | 1,076 |  |  | — |  |  | — |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (18,585) |  |  | — |
Cash flow hedge unrealized loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (941) |
Balance, at September 29, 2019 | 58,433 |  |  | $ | 5,843 |  |  | $ | 248,524 |  |  | $ | 273,421 |  |  | $ | (41,796) |  |  | $ | (121,026) |  |  | $ | (7,588) |

Stock Option Awards
In accordance with accounting standards, the Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. That cost will be recognized over the period in which the employee is required to provide the services – the requisite service period (usually the vesting period) – in exchange for the award.
-17-

Table of Contents
All outstanding stock options vested prior to the end of 2013, and therefore there was no stock option compensation expense in the first nine months of 2020 or 2019.
As of October 4, 2020, there were no stock options outstanding and exercisable. There were no stock options granted in the first nine months of 2020 or 2019. There were 7,500 stock options exercised and 20,000 stock options expired in the first nine months of 2020. There were 10,000 stock options exercised in the first nine months of 2019 and 5,000 stock option forfeitures during those nine months.
Restricted Stock Awards
During the nine months ended October 4, 2020 and September 29, 2019, the Company granted restricted stock awards for 308,100 and 224,000 shares of common stock, respectively. Awards of restricted stock (or a portion thereof) vest with respect to each recipient over a one to three-year period from the date of grant, provided the individual remains in the employment or service of the Company as of the vesting date. Additionally, certain awards (or a portion thereof) could vest earlier in the event of a change in control of the Company, or upon involuntary termination without cause.
Compensation expense related to restricted stock grants was $0.6 million and $2.5 million for the nine months ended October 4, 2020, and September 29, 2019, respectively. The Company has reduced its expense for restricted stock forfeited during the period.
The following table summarizes restricted stock outstanding as of October 4, 2020, as well as activity during the nine months then ended:

| Restricted Shares |  | Weighted Average Grant Date Fair Value
Outstanding at December 29, 2019 | 468,200 |  |  | $ | 28.63 |
Granted | 308,100 |  |  | 13.08 |
Vested | (167,000) |  |  | 19.33 |
Forfeited or canceled | (157,800) |  |  | 19.59 |
Outstanding at October 4, 2020 | 451,500 |  |  | $ | 24.62 |

As of October 4, 2020, the unrecognized total compensation cost related to unvested restricted stock was $3.8 million. That cost is expected to be recognized by the end of 2023.
Performance Share Awards
During the nine months ended October 4, 2020 and September 29, 2019, the Company issued awards of performance shares to certain employees. These awards vest based on the achievement of certain performance-based goals over a performance period of one to three years, subject to the employee’s continued employment, and will be settled in shares of our common stock or in cash at the Company’s election. The number of shares that may be issued in settlement of the performance shares to the award recipients may be greater (up to 200%) or lesser than the nominal award amount depending on actual performance achieved as compared to the performance targets set forth in the awards.
The following table summarizes the performance shares outstanding as of October 4, 2020, as well as the activity during the nine months then ended:

| Performance Shares |  | Weighted Average Grant Date Fair Value
Outstanding at December 29, 2019 | 512,000 |  |  | $ | 19.71 |
Granted | 263,700 |  |  | 15.36 |
Vested | (164,300) |  |  | 19.74 |
Forfeited or canceled | (200,700) |  |  | 19.61 |
Outstanding at October 4, 2020 | 410,700 |  |  | $ | 16.96 |

-18-

Table of Contents
Compensation expense (benefit) related to the performance shares was $(2.0) million and $4.0 million for the nine months ended October 4, 2020 and September 29, 2019, respectively. The Company has reduced its expense for performance shares forfeited during the period. Unrecognized compensation expense related to these performance shares was approximately $6.9 million as of October 4, 2020. Depending on the performance of the Company, any compensation expense related to these outstanding performance shares will be recognized by the end of 2023.
Tax expense recognized with regard to restricted stock and performance shares was approximately $0.3 million for the nine months ended October 4, 2020.
-19-

Table of Contents
NOTE 8 – LEASES
General
The Company has operating and finance leases for manufacturing equipment, corporate offices, showrooms, distribution facilities, design centers, as well as computer and office equipment. The Company’s leases have terms ranging from 1 to 20 years, some of which may include options to extend the lease term for up to 5 years, and certain leases may include an option to terminate the lease. Our lease accounting may include these options to extend or terminate a lease when it is reasonably certain that we will exercise that option.
The Company records a right-of-use asset and lease liability for leases extending beyond one year for operating and finance leases once a contract that contains a lease is executed and we have the right to control the use of the leased asset. The right-of-use asset is measured as the present value of the lease obligation. The discount rate used to calculate the present value of the lease liability was the Company’s incremental borrowing rate for the applicable geographical region.
As of October 4, 2020, there were no significant leases that had not commenced as of the end of the third quarter.
The table below represents a summary of the balances recorded in the consolidated condensed balance sheets related to our leases as of October 4, 2020 and December 29, 2019:

| October 4, 2020 |  | December 29, 2019
Balance Sheet Location | Operating Leases |  | Finance Leases |  | Operating Leases |  | Finance Leases
| (In thousands)
Operating lease right-of-use assets | $ | 99,815 |  |  |  |  | $ | 107,044 |  |  |
Current portion of operating lease liabilities | $ | 14,015 |  |  |  |  | $ | 15,914 |  |  |
Operating lease liabilities | 87,276 |  |  |  |  | 91,829 |  |  |
Total operating lease liabilities | $ | 101,291 |  |  |  |  | $ | 107,743 |  |  |
Property and equipment |  |  | $ | 5,786 |  |  |  |  | $ | 5,007 |
Accrued expenses |  |  | $ | 1,415 |  |  |  |  | $ | 1,489 |
Other long-term liabilities |  |  | 2,299 |  |  |  |  | 1,673 |
Total finance lease liabilities |  |  | $ | 3,714 |  |  |  |  | $ | 3,162 |

Lease Costs

| Three Months Ended |  | Nine Months Ended
| October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
| (In thousands)
Finance lease cost: |  |  |  |  |  |  |
Amortization of right-of-use assets | $ | 176 |  |  | $ | 112 |  |  | $ | 811 |  |  | $ | 536 |
Interest on lease liabilities | 22 |  |  | 12 |  |  | 56 |  |  | 31 |
Operating lease cost | 6,095 |  |  | 6,023 |  |  | 19,076 |  |  | 17,624 |
Short-term lease cost | 85 |  |  | 363 |  |  | 426 |  |  | 1,509 |
Variable lease cost | 1,089 |  |  | 561 |  |  | 2,659 |  |  | 1,319 |
Total lease cost | $ | 7,467 |  |  | $ | 7,071 |  |  | $ | 23,028 |  |  | $ | 21,019 |

-20-

Table of Contents
Other Supplemental Information

| Three Months Ended |  | Nine Months Ended
| October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
| (In thousands)
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |  |
Operating cash flows from finance leases | $ | 22 |  |  | $ | 12 |  |  | $ | 56 |  |  | $ | 31 |
Operating cash flows from operating leases | 5,528 |  |  | 5,653 |  |  | 16,978 |  |  | 16,158 |
Financing cash flows from finance leases | 442 |  |  | 291 |  |  | 1,252 |  |  | 808 |
Right-of-use assets obtained in exchange for new finance lease liabilities | 1,156 |  |  | 252 |  |  | 1,709 |  |  | 803 |
Right-of-use assets obtained in exchange for new operating lease liabilities | 1,517 |  |  | 1,437 |  |  | 5,582 |  |  | 7,973 |

Lease Term and Discount Rate
The table below presents the weighted average remaining lease terms and discount rates for finance and operating leases as of October 4, 2020 and December 29, 2019:

| October 4, 2020 |  | December 29, 2019
Weighted-average remaining lease term – finance leases (in years) | 3.29 |  | 2.76
Weighted-average remaining lease term – operating leases (in years) | 10.59 |  | 10.60
Weighted-average discount rate – finance leases | 2.75 | % |  | 2.06 | %
Weighted-average discount rate – operating leases | 5.96 | % |  | 5.86 | %

Maturity Analysis
A maturity analysis of lease payments under non-cancellable leases is presented as follows:

Fiscal Year | Operating Leases |  | Finance Leases
| (In thousands)
2020 (excluding the nine months ended October 4, 2020) | $ | 5,262 |  |  | $ | 411 |
2021 | 18,529 |  |  | 1,367 |
2022 | 15,126 |  |  | 903 |
2023 | 12,464 |  |  | 680 |
2024 | 10,513 |  |  | 407 |
Thereafter | 78,668 |  |  | 153 |
Total future minimum lease payments (undiscounted) | 140,562 |  |  | 3,921 |
Less: Present value discount | (39,271) |  |  | (207) |
Total lease liability | $ | 101,291 |  |  | $ | 3,714 |

Policy Elections
The Company made an accounting policy election not to separate lease and non-lease components for all asset classes, except for data center assets, and will account for the lease payments as a single component. The Company also made an accounting policy election to exclude leases with an initial term of 12 months or less from the calculation of the right-of-use asset and lease liability recorded on the consolidated condensed balance sheets. These leases primarily represent month-to-month operating leases for vehicles and office equipment where we were reasonably certain that we would not elect an option to extend the lease.
-21-

Table of Contents
NOTE 9 – EMPLOYEE BENEFIT PLANS
On December 31, 2019, a plan amendment was executed to eliminate future service accruals in the Dutch defined benefit plan, resulting in a curtailment of the plan. This plan remains in existence and will continue to pay vested benefits. Active participants will no longer accrue benefits after December 31, 2019, and instead will participate in an industry-wide multi-employer plan beginning in fiscal year 2020. During the three and nine months ended October 4, 2020, the Company recorded multi-employer pension expense related to multi-employer contributions of $0.6 million and $1.9 million, respectively.
The following tables provide the components of net periodic benefit cost for the three and nine months ended October 4, 2020 and September 29, 2019:

| Three Months Ended |  | Nine Months Ended
Defined Benefit Retirement Plans (Europe) | October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
| (In thousands)
Service cost | $ | — |  |  | $ | 181 |  |  | $ | — |  |  | $ | 550 |
Interest cost | 907 |  |  | 1,223 |  |  | 2,668 |  |  | 3,770 |
Expected return on assets | (1,082) |  |  | (1,378) |  |  | (3,184) |  |  | (4,251) |
Amortization of prior service cost | 27 |  |  | 16 |  |  | 79 |  |  | 48 |
Amortization of net actuarial losses | 335 |  |  | 240 |  |  | 981 |  |  | 742 |
Net periodic benefit cost | $ | 187 |  |  | $ | 282 |  |  | $ | 544 |  |  | $ | 859 |

| Three Months Ended |  | Nine Months Ended
Salary Continuation Plan | October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
| (In thousands)
Interest cost | $ | 234 |  |  | $ | 288 |  |  | $ | 703 |  |  | $ | 865 |
Amortization of net actuarial losses | 140 |  |  | 94 |  |  | 419 |  |  | 281 |
Net periodic benefit cost | $ | 374 |  |  | $ | 382 |  |  | $ | 1,122 |  |  | $ | 1,146 |

| Three Months Ended |  | Nine Months Ended
nora Defined Benefit Plan | October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
| (In thousands)
Service cost | $ | 274 |  |  | $ | 213 |  |  | $ | 791 |  |  | $ | 646 |
Interest cost | 117 |  |  | 170 |  |  | 338 |  |  | 515 |
Amortization of net actuarial losses | 58 |  |  | — |  |  | 168 |  |  | — |
Net periodic benefit cost | $ | 449 |  |  | $ | 383 |  |  | $ | 1,297 |  |  | $ | 1,161 |

In accordance with applicable accounting standards, the service cost component of net periodic benefit costs is presented within Operating Income in the consolidated condensed statements of operations, while all other components of net periodic benefit costs are presented within other expense in the consolidated condensed statements of operations.
-22-

Table of Contents
NOTE 10 – GOODWILL AND INTANGIBLE ASSETS
During the first quarter of 2020, we performed a qualitative assessment of goodwill impairment indicators, considering macroeconomic conditions related to the COVID-19 pandemic and its potential impact to sales and operating income. We expect that the duration of the COVID-19 pandemic and its adverse impacts on the global economy, global travel restrictions, COVID-19 related government shutdowns, disruptions to our supply chain, distribution disruption, and disruption to our customers’ plans to spend capital on projects that use our products and services will result in lower revenue and operating income. As a result, we determined that there were indicators of impairment, and the Company proceeded with a quantitative assessment of goodwill for all reporting units at the end of the first quarter.
In performing the first quarter quantitative goodwill impairment testing, the Company prepared valuations of reporting units on both a market comparable methodology and an income methodology, and those valuations were compared with the respective carrying values of the reporting units to determine whether any goodwill impairment existed. Our reporting units are one level below our reporting segment level. In preparing the valuations, past, present and future expectations of performance were considered, including the impact of the COVID-19 pandemic. This methodology was consistent with the approach used to perform the annual quantitative goodwill assessment in prior years. The weighted average cost of capital used in the goodwill impairment testing ranged between 10.0% and 10.5%, which primarily fluctuated based on a country risk premium assigned to the geographical region of the reporting unit. There is inherent uncertainty associated with key assumptions used in our impairment testing including the duration of the economic downturn associated with the COVID-19 pandemic and the recovery period. As a result of the first quarter assessment, we determined that the fair value for two reporting units was less than the carrying value and recognized a goodwill impairment loss of $116.5 million in the first quarter of 2020. The expected decline in revenue due to the impact of COVID-19 contributed to the lower fair value of our Europe and Asia-Pacific reporting units. As such, the goodwill impairment loss was allocated to our Europe and Asia-Pacific reporting units in the amounts of $99.2 million and $17.3 million, respectively. We determined that the goodwill in our Americas reporting unit was not impaired as the fair value exceeded the carrying value by more than 90% at April 5, 2020. There were no indicators of additional goodwill impairment as of October 4, 2020.
The changes in the carrying amounts of goodwill for the nine months ended October 4, 2020 are as follows:

BALANCE, AT DECEMBER 30, 2019 |  | ACQUISITIONS |  | PURCHASE PRICE ACCOUNTING ADJUSTMENTS |  | IMPAIRMENT |  | FOREIGN CURRENCY TRANSLATION |  | BALANCE, AT OCTOBER 4, 2020
(In thousands)
$ | 257,439 |  |  | $ | — |  |  | $ | — |  |  | $ | (116,495) |  |  | $ | 13,686 |  |  | $ | 154,630 |

Additionally, we determined that the trademarks and trade names intangible assets related to the acquired nora business were also impaired and recognized an impairment loss of $4.8 million in the first quarter of 2020. The carrying value of intangible assets after the impairment was $85.5 million at October 4, 2020. There were no indicators of additional intangible asset impairment as of the end of the third quarter of 2020.
-23-

Table of Contents
NOTE 11 – SEGMENT INFORMATION
Based on applicable accounting standards, the Company has determined that it has three operating segments – namely, the Americas, Europe and Asia-Pacific geographic regions. Pursuant to accounting standards, the Company has aggregated the three operating segments into one reportable segment because they have similar economic characteristics, and the operating segments are similar in all of the following areas: (a) the nature of the products and services; (b) the nature of the production processes; (c) the type or class of customer for their products and services; (d) the methods used to distribute their products or provide their services; and (e) the nature of the regulatory environment.
While the Company operates as one reportable segment for the reasons discussed, included below is selected information on our operating segments.
Summary information by operating segment follows:

| AMERICAS |  | EUROPE |  | ASIA- PACIFIC |  | TOTAL
| (In thousands)
Three Months Ended October 4, 2020: |  |  |  |  |  |  |
Net Sales | $ | 142,858 |  |  | $ | 92,905 |  |  | $ | 42,879 |  |  | $ | 278,642 |
Depreciation and amortization | 3,554 |  |  | 4,590 |  |  | 1,911 |  |  | 10,055 |
Total assets | 749,577 |  |  | 491,155 |  |  | 186,166 |  |  | 1,426,898 |
Three Months Ended September 29, 2019: |  |  |  |  |  |  |
Net Sales | $ | 195,900 |  |  | $ | 106,115 |  |  | $ | 46,337 |  |  | $ | 348,352 |
Depreciation and amortization | 3,238 |  |  | 4,255 |  |  | 2,035 |  |  | 9,528 |
Nine Months Ended October 4, 2020: |  |  |  |  |  |  |
Net Sales | $ | 452,171 |  |  | $ | 259,469 |  |  | $ | 114,675 |  |  | $ | 826,315 |
Depreciation and amortization | 9,623 |  |  | 13,448 |  |  | 5,848 |  |  | 28,919 |
Nine Months Ended September 29, 2019: |  |  |  |  |  |  |
Net Sales | $ | 563,776 |  |  | $ | 294,830 |  |  | $ | 144,941 |  |  | $ | 1,003,547 |
Depreciation and amortization | 9,789 |  |  | 13,586 |  |  | 6,275 |  |  | 29,650 |

A reconciliation of the Company’s total operating segment depreciation and amortization and assets to the corresponding consolidated amounts follows:

| Three Months Ended |  | Nine Months Ended
Depreciation and Amortization | October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
| (In thousands)
Total segment depreciation and amortization | $ | 10,055 |  |  | $ | 9,528 |  |  | $ | 28,919 |  |  | $ | 29,650 |
Corporate depreciation and amortization | 1,677 |  |  | 1,352 |  |  | 4,561 |  |  | 3,928 |
Reported depreciation and amortization | $ | 11,732 |  |  | $ | 10,880 |  |  | $ | 33,480 |  |  | $ | 33,578 |

Assets | October 4, 2020
| (In thousands)
Total segment assets | $ | 1,426,898 |
Corporate assets | 132,029 |
Eliminations | (253,152) |
Reported total assets | $ | 1,305,775 |

-24-

Table of Contents
NOTE 12 – SUPPLEMENTAL CASH FLOW INFORMATION
Cash payments for interest amounted to $16.0 million and $18.1 million for the nine months ended October 4, 2020 and September 29, 2019, respectively. Income tax payments, net of refunds, amounted to $8.2 million and $26.5 million for the nine months ended October 4, 2020 and September 29, 2019, respectively.
See Note 8 entitled “Leases” for supplemental disclosures related to finance and operating leases.
-25-

Table of Contents
NOTE 13 – INCOME TAXES
The Company determines its provision for income taxes for interim periods using an estimate of its annual effective tax rate and records any changes affecting the estimated annual effective tax rate in the interim period in which the change occurs, including discrete tax items.
During the nine months ended October 4, 2020, the Company recorded a total income tax provision of $5.7 million on a pre-tax loss of $85.8 million resulting in an effective tax rate of (6.7)%. The effective tax rate for this period was primarily impacted by a non-deductible goodwill impairment. Excluding the impact of the goodwill impairment, the effective tax rate was 18.7% for the period compared to 22.0% during the nine months ended September 29, 2019. The decrease in the effective tax rate, excluding the goodwill impairment, was due to favorable impacts of amending prior year tax returns and the retroactive election of the GILTI High-tax Exclusion in the 2019 tax return, which were offset by the unfavorable changes related to unrecognized tax benefits and the non-deductible penalty to settle the SEC matter, referenced in the disclosure set forth in Note 17 to the consolidated financial statements included in Item 8 of the December 29, 2019 Annual Report on Form 10-K.
In the first nine months of 2020, the Company increased its liability for unrecognized tax benefits by $0.1 million. As of October 4, 2020, the Company had accrued approximately $25.6 million for unrecognized tax benefits. In accordance with applicable accounting standards, the Company’s deferred tax asset as of October 4, 2020 reflects a reduction for $2.8 million of these unrecognized tax benefits.
In October 2020, the statute of limitations for the 2016 U.S. federal income tax return closed. As a result of this lapse in the statute of limitations, the Company will recognize $14.4 million of unrecognized tax benefits in the fourth quarter of 2020.
On March 27, 2020, the CARES Act was signed into law in response to the COVID-19 pandemic and provides certain tax relief to businesses. Tax provisions of the CARES Act include, among other things, the deferral of certain payroll taxes, relief for retaining employees, and certain income tax provisions for corporations. During the nine months ended October 4, 2020, the Company deferred approximately $2.9 million in payroll taxes under the CARES Act. Other than the deferral of payroll taxes, the CARES Act did not have an impact on the Company’s tax accounts, including its effective tax rate, during the nine months ended October 4, 2020. The Company expects it will defer approximately $4.0 million in payroll taxes under the CARES Act during fiscal year 2020 which will result in a corresponding increase in its payroll tax accrual. The CARES Act and other similar foreign government support programs are not expected to have a material impact on the Company’s tax accounts during the year.
-26-

Table of Contents
NOTE 14 – ITEMS RECLASSIFIED FROM ACCUMULATED OTHER COMPREHENSIVE LOSS
Amounts reclassified out of accumulated other comprehensive income (loss) (“AOCI”) to the consolidated condensed statements of operations during the three and nine months ended October 4, 2020 and September 29, 2019 are reflected in the tables below:

|  |  | Three Months Ended
| Statement of Operations Location |  | October 4, 2020 |  | September 29, 2019
|  |  | (In thousands)
Foreign currency contracts loss | Cost of sales |  | $ | — |  |  | $ | (450) |
Interest rate swap contracts gain (loss) | Interest expense |  | (1,328) |  |  | 55 |
Amortization of benefit plan prior service cost and net actuarial losses | Other expense |  | (560) |  |  | (350) |
Total loss reclassified from AOCI, net |  |  | $ | (1,888) |  |  | $ | (745) |
|  |  | Nine Months Ended
| Statement of Operations Location |  | October 4, 2020 |  | September 29, 2019
|  |  | (In thousands)
Foreign currency contracts loss | Cost of sales |  | $ | — |  |  | $ | (450) |
Interest rate swap contracts gain (loss) | Interest expense |  | (2,944) |  |  | 350 |
Amortization of benefit plan prior service cost and net actuarial losses | Other expense |  | (1,647) |  |  | (1,071) |
Total loss reclassified from AOCI, net |  |  | $ | (4,591) |  |  | $ | (1,171) |

-27-

Table of Contents
NOTE 15 – RESTRUCTURING CHARGES
For the nine months ended October 4, 2020, the Company recorded a reduction of $3.2 million of previously recognized restructuring charges due to changes in expected cash payments. At October 4, 2020, the aggregate restructuring reserve was $3.9 million for both the 2019 and 2018 restructuring plans. Below is a discussion of the restructuring plan activities by year.
2019 Restructuring Plan
On December 23, 2019, the Company committed to a new restructuring plan that continues to focus on efforts to improve efficiencies and decrease costs across its worldwide operations, and more closely align its operating structure with its business strategy. The plan involved a reduction of approximately 105 employees and early termination of two office leases. As a result of this plan, the Company recorded a pre-tax restructuring charge in the fourth quarter of 2019 of approximately $9.0 million. The charge was comprised of severance expenses ($8.8 million) and lease exit costs ($0.2 million).
The restructuring plan is expected to result in cash expenditures of approximately $9.0 million for payment of the employee severance and lease exit costs, as described above. The Company expects to complete the restructuring plan in fiscal year 2020 and expects the plan to yield annualized savings of approximately $6.0 million. A portion of the annualized savings is expected to be realized on the income statement in fiscal year 2020, with the remaining portion of the annualized savings expected to be realized in fiscal year 2021.
A reconciliation of the 2019 plan restructuring reserve is presented below:

| BALANCE, AT DECEMBER 30, 2019 |  | DEDUCTIONS 2020 |  | CHARGED TO EXPENSES 2020 |  | BALANCE, AT OCTOBER 4, 2020
| (In thousands)
Workforce Reduction | $ | 8,634 |  |  | $ | (2,648) |  |  | $ | (2,234) |  |  | $ | 3,752 |
Other Exit Costs | 139 |  |  | (139) |  |  | — |  |  | — |
Total | $ | 8,773 |  |  | $ | (2,787) |  |  | $ | (2,234) |  |  | $ | 3,752 |

2018 Restructuring Plan
On December 29, 2018, the Company committed to a restructuring plan in its continuing efforts to improve efficiencies and decrease costs across its worldwide operations, and more closely align its operating structure with its business strategy. The plan involved (i) a restructuring of its sales and administrative operations in the United Kingdom, (ii) a reduction of approximately 200 employees, primarily in the Europe and Asia-Pacific geographic regions, and (iii) the write-down of certain underutilized and impaired assets that included information technology assets and obsolete manufacturing equipment.
The restructuring plan was substantially completed at the end of the second quarter of 2020. The Company redeployed essentially all of the anticipated savings toward the funding of sales and strategic growth initiatives, yielding negligible net savings on the Company’s income statement.
A reconciliation of the 2018 plan restructuring reserve is presented below:

| BALANCE, AT DECEMBER 30, 2019 |  | DEDUCTIONS 2020 |  | CHARGED TO EXPENSES 2020 |  | BALANCE, AT OCTOBER 4, 2020
| (In thousands)
Workforce Reduction | $ | 1,898 |  |  | $ | (1,576) |  |  | $ | (223) |  |  | $ | 99 |
Other Exit Costs | 774 |  |  | (75) |  |  | (699) |  |  | — |
Total | $ | 2,672 |  |  | $ | (1,651) |  |  | $ | (922) |  |  | $ | 99 |

-28-

Table of Contents
NOTE 16 – SUBSEQUENT EVENTS
Cost Reducing Initiatives and Related Charges
As we continue to monitor the impact of COVID-19 and mitigate its effects to our operations, the Company expects to continue to pursue a variety of cost reducing initiatives including but not limited to voluntary incentive separation programs, temporary employee furloughs and other time-and-pay reduction programs, applications to participate in various government sponsored “wage support” programs, involuntary separations where necessary to streamline roles and responsibilities, potential facility closures to streamline operations, and various other cost reducing and cost avoidance activities.
Unrecognized Tax Benefits
In October 2020, the statute of limitations for the 2016 U.S. federal income tax return closed. As a result of this lapse in the statute of limitations, the Company will recognize $14.4 million of unrecognized tax benefits in the fourth quarter of 2020.
-29-

Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Our discussions below in this Item 2 are based upon the more detailed discussions about our business, operations and financial condition included in our Annual Report on Form 10-K for the fiscal year ended December 29, 2019, under Part II, Item 7 of that Form 10-K. Our discussions here focus on our results during the quarter ended, or as of, October 4, 2020, and the comparable periods of 2019 for comparison purposes, and, to the extent applicable, any material changes from the information discussed in that Form 10-K or other important intervening developments or information since that time. These discussions should be read in conjunction with that Form 10-K for more detailed and background information. The nine month period ended October 4, 2020 includes 40 weeks, and the nine month period ended September 29, 2019 includes 39 weeks. The three month periods ended October 4, 2020 and September 29, 2019 both include 13 weeks.
Forward-Looking Statements
This report contains statements which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include risks and uncertainties associated with the ongoing COVID-19 pandemic and the economic conditions in the commercial interiors industry as well as the risks and uncertainties discussed under the heading “Risk Factors” included in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 29, 2019, as supplemented by the additional risk factors included in Part II, Item 1A of this Form 10-Q and the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended April 5, 2020. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.
-30-

Table of Contents
Impact of the COVID-19 Pandemic
The World Health Organization declared the COVID-19 outbreak a pandemic, and the virus continues to spread in areas where we operate and sell our products and services. The COVID-19 pandemic has had material adverse effects on our business, results of operations, and financial condition, and it is anticipated that this will continue for an indefinite period of time. The duration of the pandemic will ultimately determine the extent to which our operations are impacted. We continue to monitor our operations and have implemented various programs to mitigate the effects on our business including reductions in employees, labor costs, marketing expenses, consulting expenses, travel costs, various other costs, and capital expenditures, as well as reducing the amount of the cash dividend that we pay on our common stock and suspending and reducing shifts in our production facilities, temporarily furloughing employees, and implementing other cost reduction or avoidance initiatives.
During the third quarter of 2020, the COVID-19 pandemic continued to impact our global operations, resulting in lower revenue across all geographic regions. For the three months ended October 4, 2020, consolidated net sales declined 20.0% compared to the same period last year. As discussed above, the Company implemented, and continues to implement, various cost cutting initiatives to mitigate the effects of COVID-19 on our operations. During the three and nine months ended October 4, 2020, the Company recorded $7.7 million and $10.6 million, respectively, of voluntary and involuntary severance costs, which are included in selling, general and administrative expenses in the Consolidated Condensed Statements of Operations. We anticipate future annualized savings of approximately $13 million as a result of these separation initiatives.
As a result of the COVID-19 pandemic, government grants and payroll protection programs are available in various countries globally to provide assistance to companies impacted by the pandemic. The CARES Act enacted in the United States (see Note 13 entitled “Income Taxes” of Part I, Item 1 of this 10-Q for additional information) and a payroll protection program enacted in the Netherlands (the “NOW Program”), provide benefits related to payroll costs either as reimbursements, lower payroll tax rates or deferral of payroll tax payments. The NOW Program provides eligible companies with reimbursement of labor costs as an incentive to retain employees and continue paying them in accordance with the Company’s customary compensation practices. During the third quarter of 2020, the Company qualified for benefits under several payroll protection programs and recognized a reduction in payroll costs of approximately $2.8 million, which are recorded as a $2.5 million reduction of selling, general and administrative expenses and a $0.3 million reduction of cost of sales in the Consolidated Condensed Statements of Operations, as the Company believes it is probable that the benefits received will not be repaid.
During the first nine months of 2020, consolidated net sales declined 17.7% compared to the same period last year primarily due to COVID-19. Due to reduced demand and to enhance employee safety measures, we temporarily suspended production in our U.S. manufacturing facilities from March 18, 2020 to March 23, 2020, and then again from April 6, 2020 to April 13, 2020. We also substantially reduced production in our Craigavon, UK facility beginning on April 20, 2020 through the end of the third quarter, and our Thailand, China, and Australia plants are operating in reduced shifts in light of reduced demand. During the first quarter of 2020, our Asia-Pacific region was primarily impacted by COVID-19 due to government shutdowns in China and the temporary closure of our China plant in late January 2020 to February 9, 2020. In addition, almost all of our salesforce and administrative employees globally continue to work remotely in accordance with the Company’s ongoing safety measures, as well as any local government orders and “shelter in place” directives in place from time to time. During the nine months ended October 4, 2020, the Company recognized $6.6 million of lower payroll costs due to credits recognized from various wage support programs, which are recorded as a $6.0 million reduction of selling, general and administrative expenses and a $0.6 million reduction of cost of sales in the Consolidated Condensed Statements of Operations, as the Company believes it is probable that the benefits received will not be repaid.
General
During the quarter ended October 4, 2020, net sales were $278.6 million compared with net sales of $348.4 million in the third quarter last year. During the first nine months ended October 4, 2020, net sales were $826.3 million, compared with net sales of $1,003.5 million in the first nine months of last year. The third quarter and first nine months of 2020 were negatively impacted by the effects of the COVID-19 pandemic as discussed above. Fluctuations in currency exchange rates had a positive impact on net sales of approximately $5.6 million for the third quarter of 2020 compared to the third quarter of last year, mostly driven by the strengthening of the Euro, British Pound sterling and Australian dollar against the U.S. dollar. For the first nine months of 2020, fluctuations in currency exchange rates had a negative impact on net sales of approximately $1.9 million compared to 2019, mostly driven by the weakening of the Chinese Renminbi and Australian dollar against the U.S. dollar.
-31-

Table of Contents
Goodwill, Intangible Asset and Fixed Asset Impairment
During the first quarter of 2020, we recognized a charge of $121.3 million for the impairment of goodwill and certain intangible assets. See Note 10 entitled “Goodwill and Intangible Assets” of Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information. No additional goodwill or intangible asset impairment charges were recorded during the second or third quarters of 2020. During the second quarter of 2020, we recognized fixed asset impairment charges of $3.1 million related to certain FLOR design center closures and other projects that were abandoned or indefinitely delayed. These charges are included in selling, general and administrative expenses in the Consolidated Condensed Statements of Operations. No additional fixed asset impairment charges were recorded during the third quarter.
Results of Operations
The following table presents, as a percentage of net sales, certain items included in our consolidated condensed statements of operations for the three and nine month periods ended October 4, 2020 and September 29, 2019:

| Three Months Ended |  | Nine Months Ended
| October 4, 2020 |  | September 29, 2019 |  | October 4, 2020 |  | September 29, 2019
Net sales | 100.0 | % |  | 100.0 | % |  | 100.0 | % |  | 100.0 | %
Cost of sales | 63.3 |  |  | 60.4 |  |  | 62.0 |  |  | 60.7 |
Gross profit on sales | 36.7 |  |  | 39.6 |  |  | 38.0 |  |  | 39.3 |
Selling, general and administrative expenses | 31.6 |  |  | 26.8 |  |  | 31.0 |  |  | 29.0 |
Restructuring charges | (0.7) |  |  | 0.2 |  |  | (0.4) |  |  | 0.1 |
Goodwill and intangible asset impairment charge | — |  |  | — |  |  | 14.7 |  |  | — |
Operating income (loss) | 5.8 |  |  | 12.6 |  |  | (7.3) |  |  | 10.2 |
Interest/Other expenses | 3.0 |  |  | 2.2 |  |  | 3.1 |  |  | 2.2 |
Income (loss) before tax expense | 2.8 |  |  | 10.4 |  |  | (10.4) |  |  | 8.0 |
Income tax expense | 0.6 |  |  | 2.8 |  |  | 0.7 |  |  | 1.8 |
Net income (loss) | 2.2 | % |  | 7.6 | % |  | (11.1) | % |  | 6.2 | %

Net Sales
Below is information regarding our net sales, and analysis of those results, for the three and nine month periods ended October 4, 2020, and September 29, 2019:

| Three Months Ended |  | Percentage Change
| October 4, 2020 |  | September 29, 2019 |
| (In thousands) |  |
Net Sales: |  |  |  |  |
Americas | $ | 142,858 |  |  | $ | 195,900 |  |  | (27.1) | %
Europe | 92,905 |  |  | 106,115 |  |  | (12.4) | %
Asia-Pacific | 42,879 |  |  | 46,337 |  |  | (7.5) | %
Total Net Sales | $ | 278,642 |  |  | $ | 348,352 |  |  | (20.0) | %

-32-

Table of Contents

| Nine Months Ended |  | Percentage Change
| October 4, 2020 |  | September 29, 2019 |
| (In thousands) |  |
Net Sales: |  |  |  |  |
Americas | $ | 452,171 |  |  | $ | 563,776 |  |  | (19.8) | %
Europe | 259,469 |  |  | 294,830 |  |  | (12.0) | %
Asia-Pacific | 114,675 |  |  | 144,941 |  |  | (20.9) | %
Total Net Sales | $ | 826,315 |  |  | $ | 1,003,547 |  |  | (17.7) | %

For the quarter ended October 4, 2020, net sales decreased $69.7 million (20.0%) versus the comparable period in 2019. The sales decline was primarily due to the impact of the COVID-19 pandemic as discussed above. Currency fluctuations had an approximately $5.6 million (1.6%) positive impact on third quarter 2020 sales compared to the third quarter of 2019. This currency impact was mostly due to the strengthening of the Euro, British Pound sterling and Australian dollar against the U.S. dollar. On a geographic basis, net sales in the Americas decreased 27.1%, Europe decreased 12.4% and Asia-Pacific decreased 7.5%. The sales decreases across all geographic regions were, as discussed above, due to the impacts of COVID-19, resulting in lower sales globally. The sales decrease in the Americas was most significant in the corporate, retail, healthcare, education, leisure, hospitality and transportation market segments, partially offset by increases in the residential/living market segment. On a market segment basis, the sales decrease in Europe was most significant in the corporate, public buildings and hospitality market segments, partially offset by increases in the healthcare, transportation and leisure market segments. The sales decrease in Europe was also partially offset by the strengthening of the Euro. On a market segment basis, the sales decrease in Asia-Pacific was most significant in the corporate, retail, healthcare, and hospitality market segments partially offset by increases in the education, public buildings, transportation and residential/living market segments. The sales decrease in Asia-Pacific was also partially offset by the strengthening of the Australian dollar.
For the nine months ended October 4, 2020, net sales decreased $177.2 million (17.7%) versus the comparable period in 2019. The sales decline was primarily due to the impact of the COVID-19 pandemic, as discussed above, and was more pronounced in the second and third quarters as the effects of the pandemic did not begin to impact our business substantially until the end of the first quarter. Currency fluctuations had an approximately $1.9 million (0.2%) negative impact on net sales for the first nine months of 2020 compared to the first nine months of 2019. This currency impact was mostly due to the weakening of the Australian dollar and Chinese Renminbi against the U.S. dollar. On a geographic basis, net sales for the first nine months of 2020 in the Americas decreased 19.8%, Europe decreased 12.0% and Asia-Pacific decreased 20.9%. The sales decreases across all geographic regions were, as discussed above, due to the impacts of COVID-19, resulting in lower sales globally. The sales decrease in the Americas was seen in the corporate, retail, healthcare, transportation and leisure market segments, partially offset by increases in the education, public buildings and residential/living market segments. On a market segment basis, the sales decrease in Europe was most significant in the corporate, retail, public buildings, residential/living and hospitality market segments, partially offset by increases in the healthcare, education, leisure and transportation market segments. The sales decrease in the Asia-Pacific region was impacted by COVID-19 shutdowns and the weakening of the Chinese Renminbi and Australian dollar. On a market segment basis, the sales decrease in Asia-Pacific was most significant in the corporate, retail, healthcare, public buildings, hospitality and transportation market segments partially offset by increases in the education, leisure, and residential/living market segment.
Cost and Expenses
The following tables present our overall cost of sales and selling, general and administrative expenses for the three and nine month periods ended October 4, 2020, and September 29, 2019:

| Three Months Ended |  | Percentage Change
| October 4, 2020 |  | September 29, 2019 |
| (In thousands) |  |
Cost of sales | $ | 176,480 |  |  | $ | 210,608 |  |  | (16.2) | %
Selling, general and administrative expenses | 88,161 |  |  | 93,396 |  |  | (5.6) | %

-33-

Table of Contents

| Nine Months Ended |  | Percentage Change
| October 4, 2020 |  | September 29, 2019 |
| (In thousands) |  |
Cost of sales | $ | 512,548 |  |  | $ | 608,551 |  |  | (15.8) | %
Selling, general and administrative expenses | 255,902 |  |  | 291,369 |  |  | (12.2) | %

For the quarter ended October 4, 2020, cost of sales decreased $34.1 million (16.2%) compared to the third quarter of 2019, primarily due to lower net sales. Currency translation had an approximately $3.3 million (1.6%) negative impact on the year-over-year comparison. As a percentage of net sales, our cost of sales increased to 63.3% for the third quarter of 2020 versus 60.4% for the third quarter of 2019.
For the nine months ended October 4, 2020, cost of sales decreased $96.0 million (15.8%) compared to the first nine months of 2019, primarily due to lower net sales. Currency translation had an approximately $2.0 million (0.3%) positive impact on the year-over-year comparison. As a percentage of net sales, our cost of sales increased to 62.0% for the first nine months of 2020 versus 60.7% for the first nine months of 2019.
For the quarter ended October 4, 2020, selling, general and administrative (“SG&A”) expenses decreased $5.2 million (5.6%) versus the comparable period in 2019. Currency translation had a $1.4 million (1.5%) negative impact on the year-over-year comparison. SG&A expenses were lower for the third quarter of 2020 primarily due to (1) lower selling expenses of $12.8 million due to lower net sales, (2) $2.5 million of wage support program credits, (3) lower overall payroll costs due to lower performance-based incentive compensation as well as the impact of voluntary and involuntary employee separations and furloughs, which were partially offset by $7.7 million of severance expenses recorded during the quarter, and (4) a $5.0 million fine to settle the SEC matter as referenced in Part II, Item 1, “Legal Proceedings,” of this Quarterly Report on Form 10-Q. As a percentage of sales, SG&A expenses increased to 31.6% for the third quarter of 2020 versus 26.8% for the third quarter of 2019.
For the nine months ended October 4, 2020, SG&A expenses decreased $35.5 million (12.2%) versus the comparable period in 2019. Currency translation did not have a significant impact on the year-over-year comparison. SG&A expenses were lower for the first nine months of 2020 primarily due to (1) lower selling expenses of $38.2 million due to lower net sales, (2) lower stock compensation expense of $7.9 million, (3) $6.0 million of wage support program credits, and (4) lower overall payroll costs due to furloughs and separations offset by $10.6 million of severance expenses recorded year to date, and (5) the SEC settlement expense discussed above. As a percentage of sales, SG&A expenses increased to 31.0% for the first nine months of 2020 versus 29.0% for the first nine months of 2019.
Other Expense
For the quarter ended October 4, 2020, other expenses increased $1.9 million compared to 2019 primarily due to foreign currency transaction losses recognized during the quarter. During the nine months ended October 4, 2020, other expenses increased $7.2 million compared to 2019 primarily due to a $4.2 million write-down of damaged raw material inventory as a result of a fire at a storage facility in the second quarter of 2020.
Interest Expense
For the quarter ended October 4, 2020, interest expense decreased $1.2 million, from $6.6 million in the comparable period last year to $5.4 million, primarily due to lower interest rates and lower debt balances. For the nine months ended October 4, 2020, interest expense decreased $4.2 million, from $20.2 million in the comparable period last year to $16.0 million, primarily due to lower interest rates.
-34-

Table of Contents
Liquidity and Capital Resources
General
At October 4, 2020, we had $103.7 million in cash. At that date, we had $562.3 million in term loan borrowing, $23.7 million of revolving loan borrowings, and $1.6 million in letters of credit outstanding under our Syndicated Credit Facility. As of October 4, 2020, we had additional borrowing capacity of $274.7 million under the Syndicated Credit Facility and $9.6 million of borrowing capacity under other credit facilities in place at other non-U.S. subsidiaries. We anticipate that our liquidity is sufficient to meet our obligations for the next 12 months.
Amendment of Credit Facility Due to COVID-19 Impact
On July 15, 2020, we entered into a second amendment to our Syndicated Credit Facility. See Note 5 entitled “Long-Term Debt” within Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.
Analysis of Cash Flows
The following table presents a summary of cash flows for the nine month periods ended October 4, 2020 and September 29, 2019, respectively:

| Nine Months Ended
| October 4, 2020 |  | September 29, 2019
| (In thousands)
Net cash provided by (used in): |  |  |
Operating activities | $ | 97,268 |  |  | $ | 89,904 |
Investing activities | (47,067) |  |  | (53,796) |
Financing activities | (30,183) |  |  | (30,157) |
Effect of exchange rate changes on cash | 2,400 |  |  | (1,728) |
Net change in cash and cash equivalents | 22,418 |  |  | 4,223 |
Cash and cash equivalents at beginning of period | 81,301 |  |  | 80,989 |
Cash and cash equivalents at end of period | $ | 103,719 |  |  | $ | 85,212 |

Cash provided by operating activities was $97.3 million for the nine months ended October 4, 2020, which represents an increase of $7.4 million from the prior year comparable period. The increase was primarily due to working capital changes, specifically an increase in accounts receivable collections and lower inventories, offset by the change to accounts payable and accrued expenses.
Cash used in investing activities was $47.1 million for the nine months ended October 4, 2020, which represents a decrease of $6.7 million from the prior year comparable period. The decrease was primarily due to a decrease in capital expenditures from the prior year comparable period.
Cash used in financing activities was $30.2 million for the nine months ended October 4, 2020, which is consistent with the prior year comparable period. Financing activities for 2020 include higher repayments of revolving loan borrowings offset by lower dividends paid and no repurchases of common stock compared to the prior year comparable period.
Purchase Obligations
We have outstanding purchase obligations of $6.8 million related to expanding our manufacturing capabilities, which we expect to fund during the remainder of 2020.
-35-

Table of Contents
Forward-Looking Statement on Impact of COVID-19
While we are aggressively managing our response to the COVID-19 pandemic, its impacts on our full year fiscal 2020 results and beyond are uncertain. We believe the most significant elements of uncertainty are (1) the intensity and duration of the impact on construction, renovation, and remodeling; (2) corporate, government, and consumer spending levels and sentiment; and (3) the ability of our sales channels, supply chain, manufacturing, and distribution partners to continue operating through disruptions. Any or all of these factors could negatively impact our financial position, results of operations, cash flows, and outlook. As the impact of the COVID-19 pandemic continues to affect companies with global operations, we anticipate that our business and results in the fourth quarter of 2020 will continue to be adversely affected, and the timeline and pace of recovery is uncertain. While we are unable to predict with certainty, we anticipate continued year-over-year declines in revenue and operating income in the fourth quarter of fiscal year 2020, and perhaps during quarterly periods thereafter.
The Company has implemented several cost reduction and avoidance initiatives to align with anticipated customer demand, including a voluntary employee separation program, temporary employee furloughs and other time-and-pay reduction programs, involuntary employee separations where necessary to streamline roles and responsibilities, and various other cost reducing initiatives. The Company has also suspended merit-based salary increases, as well as its 401(k) and Non-Qualified Savings Plan (NSP) matching contributions, and will benefit from lower than originally anticipated performance-based compensation and variable compensation for 2020. In addition, the Company has reduced its capital spending plans.
Starting in January 2021 the Company may resume its 401(k) and NSP matching contributions on a prospective basis, as well as customary merit-based salary increases for fiscal year 2021. The Company will also need to establish new performance-based compensation and variable compensation targets for fiscal year 2021. All of these items will increase costs compared to fiscal year 2020.
Cash flows from operations, cash and cash equivalents, and other sources of liquidity are expected to be available and sufficient to meet foreseeable cash requirements. However, the Company’s cash flows from operations can be affected by numerous factors including the uncertainty of COVID-19 and its impact on global operations, raw material availability and cost, demand for our products, and other factors described in “Risk Factors” included in Part II, Item 1A of this Quarterly Report on Form 10-Q.
Backlog
As of October 25, 2020, the consolidated backlog of orders was approximately $189.4 million. As disclosed in our Annual Report on Form 10-K for the fiscal year ended December 29, 2019, backlog was approximately $177.8 million as of February 9, 2020. Disruptions in supply and distribution chains, global travel restrictions and government shelter in place orders due to the impact of COVID-19 have resulted in delays of construction projects and flooring installations in many regions worldwide.
-36-

Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The discussion below in this Item 3 is based upon the more detailed discussions of our market risk and related matters included in our Annual Report on Form 10-K for the fiscal year ended December 29, 2019, under Part II, Item 7A of that Form 10-K. The discussion here focuses on the nine months ended October 4, 2020, and any material changes from (or other important intervening developments since the time of) the information discussed in that Form 10-K. This discussion should be read in conjunction with that Form 10-K for more detailed and background information.
Sensitivity Analysis
For purposes of specific risk analysis, we use sensitivity analysis to measure the impact that market risk may have on the fair values of our market sensitive instruments. To perform sensitivity analysis, we assess the risk of loss in fair values associated with the impact of hypothetical changes in interest rates and foreign currency exchange rates on market sensitive instruments.
Because the debt outstanding under our Syndicated Credit Facility has variable interest rates based on an underlying prime lending rate or LIBOR rate, we do not believe changes in interest rates would have any significant impact on the fair value of that debt instrument. Changes in the underlying prime lending rate or LIBOR rate would, however, impact the amount of our interest expense. For a discussion of these hypothetical impacts on our interest expense, please see the discussion in Part II, Item 7A of our Annual Report on Form 10-K for the year ended December 29, 2019.
As of October 4, 2020, a 10% decrease or increase in the levels of foreign currency exchange rates against the U.S. dollar, with all other variables held constant, would result in a decrease in the fair value of our financial instruments of $11.8 million or an increase in the fair value of our financial instruments of $14.5 million, respectively. As the impact of offsetting changes in the fair market value of our net foreign investments is not included in the sensitivity model, these results are not indicative of our actual exposure to foreign currency exchange risk.
As of October 4, 2020, a 100 basis point decrease in interest rates would result in an increase in the recorded liability of our interest rate swaps of approximately $5.0 million while a 100 basis point increase in interest rates would result in a decrease in the recorded liability of our interest rate swaps of approximately $6.3 million.
-37-

Table of Contents
ITEM 4. CONTROLS AND PROCEDURES
As of the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was performed under the supervision and with the participation of our management, including our President and Chief Executive Officer and our Vice President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Act”), pursuant to Rule 13a-14(c) under the Act.
No system of controls, no matter how well designed and operated, can provide absolute assurance that the objectives of the system of controls are met, and no evaluation of controls can provide absolute assurance that the system of controls has operated effectively in all cases. Our disclosure controls and procedures however are designed to provide reasonable assurance that the objectives of disclosure controls and procedures are met.
Based on the evaluation, our President and Chief Executive Officer and our Vice President and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report to provide reasonable assurance that the objectives of disclosure controls and procedures are met.
There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
-38-

Table of Contents
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
As previously reported, since November 2017 the Securities & Exchange Commission (the “SEC”) had been conducting an investigation into the Company’s historical quarterly earnings per share calculations and rounding practices during the period 2014-2017. In the third quarter of 2020, the Company successfully reached a settlement with the SEC in this matter. The Company consented to the entry of an order by the SEC which states, among other things, that the Company was negligent in making certain accounting entries in 2015 and 2016. As part of the settlement, the Company did not admit or deny any wrongdoing. The Company paid a $5 million fine to resolve the matter, and was ordered to cease-and-desist from violating certain federal securities laws.
From time to time, we are a party to legal proceedings, whether arising in the ordinary course of business or otherwise. The disclosure under the heading “Lawsuit by Former CEO in Connection with Termination” set forth in Note 17 to the consolidated financial statements included in Item 8 of the December 29, 2019 Annual Report on Form 10-K is incorporated by reference herein.
ITEM 1A. RISK FACTORS
In addition to the other information set forth in this report, you should carefully consider the risk factors disclosed in Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the year ended December 29, 2019, as supplemented by Part II, Item 1A of our Quarterly Report on Form 10-Q for the fiscal quarter ended April 5, 2020, as well as the following updated risk factors:
Sales of our principal products have been and may continue to be affected by adverse economic cycles and effects in the renovation and construction of commercial and institutional buildings.
Sales of our principal products are related to the renovation and construction of commercial and institutional buildings. This activity is cyclical and has been affected by the strength of a country’s or region’s general economy, prevailing interest rates and other factors that lead to cost control measures, or reduction in the use of space, by businesses and other users of commercial or institutional space. For example, the COVID-19 pandemic may have cyclical and structural impacts on this activity resulting from job losses for office workers, reductions in the use of coworking spaces and increases in the number of people working permanently from home. The effects of cyclicality and other factors upon the corporate office segment have traditionally tended to be more pronounced than the effects upon the institutional segment. Historically, we have generated more sales in the corporate office segment than in any other market. The effects of cyclicality and other factors upon the new construction segment of the market have also tended in the past to be more pronounced than the effects upon the renovation segment. These effects may recur and could be more pronounced if global economic conditions do not improve or are weakened by negative cycles or other factors, including as a result of the continuing COVID-19 pandemic.
Our substantial international operations are subject to various political, economic and other uncertainties that could adversely affect our business results, including by restrictive taxation or other government regulation and by foreign currency fluctuations.
We have substantial international operations and intend to continue to pursue and commit resources to growth opportunities beyond the United States. Outside of the United States, we maintain manufacturing facilities in the Netherlands, the United Kingdom, China, Thailand, Australia and Germany, in addition to product showrooms designs or design studios in Canada, Mexico, Brazil, Denmark, England, France, Germany, Spain, the Netherlands, India, Australia, Norway, United Arab Emirates, Russia, Singapore, Hong Kong, Thailand, China and elsewhere. In 2019, approximately half of our net sales and a significant portion of our production were outside the United States, primarily in Europe and Asia-Pacific.
-39-

Table of Contents
International operations carry certain risks and associated costs, such as: the complexities and expense of administering a business abroad; complications in compliance with, and unexpected changes in, legal and regulatory restrictions or requirements; foreign laws, international import and export legislation; trading and investment policies; economic and political instability in the global markets; foreign currency fluctuations; exchange controls; increased nationalism and protectionism; tariffs and other trade barriers; difficulties in collecting accounts receivable; potential adverse tax consequences and increasing tax complexity or changes in tax law associated with operating in multiple tax jurisdictions; uncertainties of laws and enforcement relating to intellectual property and privacy rights; difficulty in managing a geographically dispersed workforce in compliance with diverse local laws and customs, including health and safety regulations and wage and hour laws; potential governmental expropriation (especially in countries with undemocratic or authoritarian ruling parties); and other factors depending upon the jurisdiction involved. There can be no assurance that we will not experience these risks in the future.
Risks include, for example, the uncertainty surrounding the implementation and effect of the United Kingdom’s exit from the European Union, including changes to the legal and regulatory framework that apply to the United Kingdom and its relationship with the European Union.
We also make a substantial portion of our net sales in currencies other than U.S. dollars (approximately half of 2019 net sales), which subjects us to the risks inherent in currency translations. The scope and volume of our global operations make it impossible to eliminate completely all foreign currency translation risks as an influence on our financial results.
In addition, due to our global operations, we are subject to many laws governing international relations and its international operations, including laws that prohibit improper payments to government officials and commercial customers and that restrict where we can do business, what information or products we can import and export to and from certain countries and what information we can provide to a non-U.S. government. These laws include but are not limited to the U.S. Foreign Corrupt Practices Act (FCPA), the U.K. Bribery Act 2010, the Mexican National Anticorruption System (Sistema Nacional Anticorrupción, or “SNA”), the U.S. Export Administration Act and U.S. and international economic sanctions and money laundering regulations. We have internal policies and procedures relating to compliance with such regulations; however, there is a risk that such policies and procedures will not always protect us from the improper acts of employees, agents, business partners, joint venture partners or representatives, particularly in the case of recently acquired operations that may not have significant training in applicable compliance policies and procedures. Violations of these laws, which are complex, may result in criminal penalties, sanctions and/or fines that could have an adverse effect on our business, financial condition and results of operations and reputation. In addition, we are subject to antitrust laws in various countries throughout the world. Changes in these laws or their interpretation, administration or enforcement may occur over time. Any such changes may limit our future acquisitions, divestitures or operations.
Finally, we may not be aware of all the factors that may affect our business in foreign jurisdictions. The risks outlined above, and others specific to certain jurisdictions that we may not be aware of, could adversely and materially affect our business and results.
We have a significant amount of debt. Our substantial indebtedness could adversely affect our business, financial condition and results of operations and our ability to meet our payment obligations under our debt.
We have a significant amount of debt and substantial debt service requirements. As of October 4, 2020, we had approximately $586.0 million of outstanding debt, all of which was secured, and we had $274.7 million of undrawn borrowing capacity under our existing credit facility.
-40-

Table of Contents
This level of debt could have significant consequences on our future operations, including:
•making it more difficult for us to meet our payment and other obligations under our outstanding debt;
•resulting in an event of default if we fail to comply with the financial and other restrictive covenants contained in our debt agreements, which event of default could result in all of our debt becoming immediately due and payable;
•reducing the availability of our cash flows to fund working capital, capital expenditures, acquisitions or strategic investments and other general corporate purposes, and limiting our ability to obtain additional financing for these purposes;
•subjecting us to the risk of increasing interest expense on variable rate indebtedness, including borrowings under our existing credit facility;
•limiting our flexibility in planning for, or reacting to, and increasing our vulnerability to, changes in our business, the industry in which we operate and the general economy;
•placing us at a competitive disadvantage compared to our competitors that have less debt or are less leveraged; and
•limiting our ability to refinance our existing indebtedness as it matures.
In addition, borrowings under our credit facility have variable interest rates, and therefore our interest expenses will increase if the underlying market rates (upon which the variable interest rates are based) increase.
Furthermore, on July 27, 2017, the U.K. Financial Conduct Authority (the “FCA”), which regulates the London interbank offered rate (“LIBOR”), announced that the FCA will no longer persuade or compel banks to submit rates for the calculation of LIBOR after 2021. This announcement indicates that the continuation of LIBOR on the current basis is not guaranteed after 2021, and LIBOR may be discontinued or modified by 2021. The Federal Reserve Bank of New York began publishing the Secured Overnight Financing Rate (“SOFR”) in April 2018 as an alternative for LIBOR. SOFR is a broad measure of the cost of borrowing cash overnight collateralized by U.S. Treasury securities. A transition away from the widespread use of LIBOR to SOFR or another benchmark rate may occur over the course of the next few years. We have exposure to LIBOR-based financial instruments, namely our floating rate credit facility. This facility allows for the use of an alternative benchmark rate if LIBOR is no longer available. At this time, we cannot predict the overall effect of the modification or discontinuation of LIBOR or the establishment of alternative benchmark rates.
Any of the above-listed factors could have an adverse effect on our business, financial condition and results of operations and our ability to meet our payment obligations under our debt.
-41-

Table of Contents
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table contains information with respect to purchases made by or on behalf of the Company, or any “affiliated purchaser” (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934), of our common stock during our third quarter ended October 4, 2020:

Period(1) |  | Total Number of Shares Purchased |  | Average Price Paid Per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |  | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
July 6 - August 2, 2020 (2) |  | 1,718 |  |  | $ | 7.22 |  |  | — |  |  | $ | — |
August 3 - August 30, 2020 (2) |  | 152 |  |  | 7.98 |  |  | — |  |  | — |
August 31 - October 4, 2020 (2) |  | — |  |  | — |  |  | — |  |  | — |
Total |  | 1,870 |  |  | $ | 7.29 |  |  | — |  |  | $ | — |

(1) The monthly periods identified above correspond to the Company’s fiscal third quarter of 2020, which commenced July 6, 2020 and ended October 4, 2020.
(2) Includes shares acquired by the Company from employees to satisfy income tax withholding obligations in connection with the vesting of previous equity awards.
-42-

Table of Contents
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None
-43-

Table of Contents
ITEM 6. EXHIBITS
The following exhibits are filed or furnished with this report:

EXHIBIT NUMBER |
31.1 | Section 302 Certification of Chief Executive Officer.
31.2 | Section 302 Certification of Chief Financial Officer.
32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. § 1350.
32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. § 1350.
101.INS | XBRL Instance Document – The Instance Document does not appear in the Interactive Data Files because its XBRL tags are embedded within the Inline XBRL document.
101.SCH | XBRL Taxonomy Extension Schema Document.
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB | XBRL Taxonomy Extension Label Linkbase Document.
101.PRE | XBRL Taxonomy Presentation Linkbase Document.
101.DEF | XBRL Taxonomy Definition Linkbase Document.
104 | The cover page from this Quarterly Report on Form 10-Q for the quarter ended October 4, 2020, formatted in Inline XBRL

-44-

Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| INTERFACE, INC.
Date: November 9, 2020 | By: | /s/ Bruce A. Hausmann
|  | Bruce A. Hausmann Chief Financial Officer (Principal Financial Officer)

-45-